SOCS-3	B-protein
is	O
tyrosine	O
phosphorylated	O
in	O
response	O
to	O
interleukin-2	B-protein
and	O
suppresses	O
STAT5	B-protein
phosphorylation	O
and	O
lymphocyte	O
proliferation	O
.	O

Members	O
of	O
the	O
recently	O
discovered	O
SOCS/CIS/SSI	B-protein
family	I-protein
have	O
been	O
proposed	O
as	O
regulators	O
of	O
cytokine	B-protein
signaling	O
,	O
and	O
while	O
targets	O
and	O
mechanisms	O
have	O
been	O
suggested	O
for	O
some	O
family	O
members	O
,	O
the	O
precise	O
role	O
of	O
these	O
proteins	O
remains	O
to	O
be	O
defined	O
.	O

To	O
date	O
no	O
SOCS	B-protein
proteins	I-protein
have	O
been	O
specifically	O
implicated	O
in	O
interleukin-2	B-protein
(	O
IL-2	B-protein
)	O
signaling	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Here	O
we	O
report	O
SOCS-3	B-protein
expression	O
in	O
response	O
to	O
IL-2	B-protein
in	O
both	O
T-cell	B-cell_line
lines	I-cell_line
and	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
.	O

SOCS-3	B-protein
protein	O
was	O
detectable	O
as	O
early	O
as	O
30	O
min	O
following	O
IL-2	B-protein
stimulation	O
,	O
while	O
CIS	B-protein
was	O
seen	O
only	O
at	O
low	O
levels	O
after	O
2	O
h	O
.	O

Unlike	O
CIS	B-protein
,	O
SOCS-3	B-protein
was	O
rapidly	O
tyrosine	O
phosphorylated	O
in	O
response	O
to	O
IL-2	B-protein
.	O

Tyrosine	O
phosphorylation	O
of	O
SOCS-3	B-protein
was	O
observed	O
upon	O
coexpression	O
with	O
Jak1	B-protein
and	O
Jak2	B-protein
but	O
only	O
weakly	O
with	O
Jak3	B-protein
.	O

In	O
these	O
experiments	O
,	O
SOCS-3	B-protein
associated	O
with	O
Jak1	B-protein
and	O
inhibited	O
Jak1	B-protein
phosphorylation	O
,	O
and	O
this	O
inhibition	O
was	O
markedly	O
enhanced	O
by	O
the	O
presence	O
of	O
IL-2	B-protein
receptor	I-protein
beta	I-protein
chain	I-protein
(	O
IL-2Rbeta	B-protein
)	O
.	O

Moreover	O
,	O
following	O
IL-2	B-protein
stimulation	O
of	O
T	B-cell_type
cells	I-cell_type
,	O
SOCS-3	B-protein
was	O
able	O
to	O
interact	O
with	O
the	O
IL-2	B-protein
receptor	I-protein
complex	I-protein
,	O
and	O
in	O
particular	O
tyrosine	B-protein
phosphorylated	I-protein
Jak1	I-protein
and	O
IL-2Rbeta	B-protein
.	O

Additionally	O
,	O
in	O
lymphocytes	B-cell_type
expressing	O
SOCS-3	B-protein
but	O
not	O
CIS	B-protein
,	O
IL-2	B-protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
STAT5b	B-protein
was	O
markedly	O
reduced	O
,	O
while	O
there	O
was	O
only	O
a	O
weak	O
effect	O
on	O
IL-3-mediated	B-protein
STAT5b	I-protein
tyrosine	O
phosphorylation	O
.	O

Finally	O
,	O
proliferation	O
induced	O
by	O
both	O
IL-2	B-protein
-and	O
IL-3	B-protein
was	O
significantly	O
inhibited	O
in	O
the	O
presence	O
of	O
SOCS-3	B-protein
.	O

The	O
findings	O
suggest	O
that	O
when	O
SOCS-3	B-protein
is	O
rapidly	O
induced	O
by	O
IL-2	B-protein
in	O
T	B-cell_type
cells	I-cell_type
,	O
it	O
acts	O
to	O
inhibit	O
IL-2	B-protein
responses	O
in	O
a	O
classical	O
negative	O
feedback	O
loop	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
July	NULL
1999	NULL
,	NULL
p.	NULL
4980-4988	NULL
0270-7306/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

SOCS-3	NULL
Is	NULL
Tyrosine	NULL
Phosphorylated	NULL
in	NULL
Response	NULL
to	NULL
Interleukin-2	NULL
and	NULL
Suppresses	NULL
STATS	NULL
Phosphorylation	NULL
and	NULL
Lymphocyte	NULL
Proliferation	NULL
SOLOMON	NULL
J.	NULL
COHNEY	NULL
,	NULL
'	NULL
DAVID	NULL
SANDEN	NULL
,	NULL
!	NULL

NICHOLAS	NULL
A.	NULL
CACALANO	NULL
,	NULL
``	NULL
AKIHIKO	NULL
YOSHIMURA	NULL
,	NULL
*	NULL
ALICE	NULL
MUI	NULL
,	NULL
*	NULL
THI	NULL
SAU	NULL
MIGONE	NULL
,	NULL
*	NULL
anp	NULL
JAMES	NULL
A.	NULL
JOHNSTON'*	NULL
DNAX	NULL
Research	NULL
Institute	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
California	NULL
94304	NULL
,	NULL
and	NULL
Institute	NULL
of	NULL
Life	NULL
Science	NULL
,	NULL
Kurume	NULL
University	NULL
,	NULL
2432-3	NULL
Aikawa-machi	NULL
,	NULL
Kurume	NULL
,	NULL
839-0861	NULL
Japan	NULL
``	NULL
Received	NULL
7	NULL
January	NULL
1999/Returned	NULL
for	NULL
modification	NULL
4	NULL
March	NULL
1999/Accepted	NULL
15	NULL
April	NULL
1999	NULL
Members	NULL
of	NULL
the	NULL
recently	NULL
discovered	NULL
SOCS/CIS/SSI	NULL
family	NULL
have	NULL
been	NULL
proposed	NULL
as	NULL
regulators	NULL
of	NULL
cytokine	NULL
signaling	NULL
,	NULL
and	NULL
while	NULL
targets	NULL
and	NULL
mechanisms	NULL
have	NULL
been	NULL
suggested	NULL
for	NULL
some	NULL
family	NULL
members	NULL
,	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
these	NULL
proteins	NULL
remains	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

To	NULL
date	NULL
no	NULL
SOCS	NULL
proteins	NULL
have	NULL
been	NULL
specifically	NULL
implicated	NULL
in	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
SOCS-3	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
in	NULL
both	NULL
T-cell	NULL
lines	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

SOCS-3	NULL
protein	NULL
was	NULL
detectable	NULL
as	NULL
early	NULL
as	NULL
30	NULL
min	NULL
following	NULL
IL-2	NULL
stimulation	NULL
,	NULL
while	NULL
CIS	NULL
was	NULL
seen	NULL
only	NULL
at	NULL
low	NULL
levels	NULL
after	NULL
2	NULL
h.	NULL
Unlike	NULL
CIS	NULL
,	NULL
SOCS-3	NULL
was	NULL
rapidly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
was	NULL
observed	NULL
upon	NULL
coexpression	NULL
with	NULL
Jak1	NULL
and	NULL
Jak2	NULL
but	NULL
only	NULL
weakly	NULL
with	NULL
Jak3	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
SOCS-3	NULL
associated	NULL
with	NULL
Jakl	NULL
and	NULL
inhibited	NULL
Jak1	NULL
phosphorylation	NULL
,	NULL
and	NULL
this	NULL
inhibition	NULL
was	NULL
markedly	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
receptor	NULL
beta	NULL
chain	NULL
(	NULL
IL-2RB	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
following	NULL
IL-2	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
SOCS-3	NULL
was	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
IL-2	NULL
receptor	NULL
complex	NULL
,	NULL
and	NULL
in	NULL
particular	NULL
tyrosine	NULL
phosphorylated	NULL
Jak1	NULL
and	NULL
IL-2Rf	NULL
.	NULL

Additionally	NULL
,	NULL
in	NULL
lymphocytes	NULL
expressing	NULL
SOCS-3	NULL
but	NULL
not	NULL
CIS	NULL
,	NULL
IL-2-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
5b	NULL
was	NULL
markedly	NULL
reduced	NULL
,	NULL
while	NULL
there	NULL
was	NULL
only	NULL
a	NULL
weak	NULL
effect	NULL
on	NULL
IL-3-mediated	NULL
STAT	NULL
Sb	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Finally	NULL
,	NULL
proliferation	NULL
induced	NULL
by	NULL
both	NULL
IL-2-	NULL
and	NULL
IL-3	NULL
was	NULL
significantly	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SOCS-3	NULL
.	NULL

The	NULL
findings	NULL
suggest	NULL
that	NULL
when	NULL
SOCS-3	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
acts	NULL
to	NULL
inhibit	NULL
IL-2	NULL
responses	NULL
in	NULL
a	NULL
classical	NULL
negative	NULL
feedback	NULL
loop	NULL
.	NULL

T-lymphocyte	NULL
proliferation	NULL
,	NULL
a	NULL
crucial	NULL
component	NULL
of	NULL
immune	NULL
responses	NULL
,	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
,	NULL
in	NULL
particular	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
.	NULL

IL-2	NULL
signals	NULL
via	NULL
a	NULL
receptor	NULL
composed	NULL
of	NULL
three	NULL
chains	NULL
IL-Z2Ra	NULL
,	NULL
IL-2R	NULL
$	NULL
,	NULL
and	NULL
y	NULL
,	NULL
,	NULL
(	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
,	NULL
shared	NULL
by	NULL
the	NULL
receptors	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
,	NULL
and	NULL
IL-15	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
receptor	NULL
components	NULL
have	NULL
no	NULL
intrinsic	NULL
kinase	NULL
activity	NULL
but	NULL
when	NULL
stimulated	NULL
dimerize	NULL
and	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
substrate	NULL
(	NULL
s	NULL
)	NULL
via	NULL
the	NULL
receptor-asso-ciated	NULL
Janus	NULL
kinases	NULL
(	NULL
Jaks	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
induce	NULL
phosphorylation	NULL
of	NULL
associated	NULL
signaling	NULL
molecules	NULL
including	NULL
the	NULL
STAT	NULL
's	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
target	NULL
genes	NULL
(	NULL
see	NULL
reference	NULL
11a	NULL
for	NULL
a	NULL
review	NULL
)	NULL
.	NULL

While	NULL
these	NULL
signaling	NULL
responses	NULL
have	NULL
been	NULL
well	NULL
character-ized	NULL
,	NULL
how	NULL
they	NULL
are	NULL
controlled	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

A	NULL
number	NULL
of	NULL
cytokines	NULL
(	NULL
notably	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
erythropoietin	NULL
[	NULL
EPO	NULL
]	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
recruit	NULL
the	NULL
inhibitory	NULL
tyrosine	NULL
phosphatase	NULL
SHP-1	NULL
(	NULL
19	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
the	NULL
cytokine-inducible	NULL
gene	NULL
CIS	NULL
(	NULL
for	NULL
cytokine-induced	NULL
SH2	NULL
[	NULL
Sre	NULL
homology	NULL
2	NULL
]	NULL
protein	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
IL-3	NULL
and	NULL
EPO	NULL
receptors	NULL
(	NULL
IL-3R	NULL
and	NULL
EPOR	NULL
)	NULL
(	NULL
29	NULL
)	NULL
and	NULL
later	NULL
shown	NULL
to	NULL
inhibit	NULL
signaling	NULL
through	NULL
these	NULL
receptors	NULL
in	NULL
an	NULL
apparent	NULL
classical	NULL
negative	NULL
feedback	NULL
loop	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Sub-sequently	NULL
,	NULL
SOCS-1/JAB/SSI-1	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
IL-6-in-duced	NULL
macrophage	NULL
differentiation	NULL
of	NULL
M1	NULL
cells	NULL
and	NULL
to	NULL
bind	NULL
to	NULL
Jak2	NULL
and	NULL
inhibit	NULL
signaling	NULL
through	NULL
it	NULL
.	NULL

A	NULL
number	NULL
of	NULL
cytokine-inducible	NULL
genes	NULL
that	NULL
along	NULL
with	NULL
CIS	NULL
and	NULL
SOCS-1	NULL
encode	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
can	NULL
modulate	NULL
cytokine	NULL
signaling	NULL
variably	NULL
called	NULL
SOCS	NULL
(	NULL
suppressors	NULL
of	NULL
cytokine	NULL
signalling	NULL
)	NULL
(	NULL
26	NULL
)	NULL
,	NULL
or	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
DNAX	NULL
Research	NULL
Institute	NULL
,	NULL
901	NULL
California	NULL
Ave.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
94304	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
650	NULL
)	NULL
858-7508	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
650	NULL
)	NULL
496-1200	NULL
.	NULL

E-mail	NULL
:	NULL
Johnston	NULL
@	NULL
dnax.org	NULL
.	NULL

4980	NULL
CIS	NULL
(	NULL
7	NULL
)	NULL
,	NULL
or	NULL
SSI	NULL
(	NULL
STAT	NULL
-induced	NULL
STAT	NULL
inhibitors	NULL
)	NULL
(	NULL
17	NULL
)	NULL
have	NULL
now	NULL
been	NULL
cloned	NULL
.	NULL

SOCS	NULL
proteins	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
central	NULL
SH2	NULL
domain	NULL
and	NULL
a	NULL
unique	NULL
motif	NULL
in	NULL
their	NULL
C-terminal	NULL
region	NULL
which	NULL
has	NULL
been	NULL
designated	NULL
a	NULL
SOCS	NULL
box	NULL
(	NULL
or	NULL
CIS	NULL
homology	NULL
domain	NULL
)	NULL
.	NULL

The	NULL
SH2	NULL
domain	NULL
,	NULL
while	NULL
enabling	NULL
interaction	NULL
with	NULL
phosphorylated	NULL
proteins	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
and	NULL
cell	NULL
activation	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
at	NULL
least	NULL
in	NULL
the	NULL
case	NULL
of	NULL
CIS	NULL
and	NULL
SOCS-1	NULL
to	NULL
be	NULL
insufficient	NULL
to	NULL
inhibit	NULL
cytokine	NULL
signaling	NULL
(	NULL
7	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
SOCS	NULL
box	NULL
is	NULL
found	NULL
in	NULL
a	NULL
number	NULL
of	NULL
other	NULL
families	NULL
of	NULL
proteins	NULL
in	NULL
association	NULL
with	NULL
other	NULL
motifs	NULL
(	NULL
WD40	NULL
repeats	NULL
,	NULL
ankyrin	NULL
repeats	NULL
,	NULL
Spry	NULL
domains	NULL
,	NULL
and	NULL
GTPase	NULL
domains	NULL
)	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
20	NULL
)	NULL
.	NULL

SOCS-3	NULL
mRNA	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
various	NULL
tissues	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
leukemia-inhibitory	NULL
factor	NULL
(	NULL
LIF	NULL
)	NULL
(	NULL
10	NULL
,	NULL
26	NULL
)	NULL
,	NULL
growth	NULL
hormone	NULL
(	NULL
GH	NULL
)	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
leptin	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Preliminary	NULL
data	NULL
has	NULL
suggested	NULL
that	NULL
SOCS-3	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
inhibitory	NULL
responses	NULL
to	NULL
LIF	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
,	NULL
GH	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
leptin	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
northern	NULL
analyses	NULL
have	NULL
shown	NULL
induction	NULL
of	NULL
SOCS-3	NULL
in	NULL
spleen	NULL
and	NULL
thymus	NULL
,	NULL
but	NULL
the	NULL
expression	NULL
and	NULL
modulation	NULL
of	NULL
the	NULL
SOCS-3	NULL
protein	NULL
in	NULL
lymphocytes	NULL
have	NULL
not	NULL
been	NULL
examined	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
SOCS-3	NULL
protein	NULL
expression	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
are	NULL
highly	NULL
regulated	NULL
by	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Significantly	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
SOCS-3	NULL
can	NULL
associate	NULL
with	NULL
components	NULL
of	NULL
the	NULL
IL-2R	NULL
complex	NULL
,	NULL
specifically	NULL
Jak1	NULL
(	NULL
but	NULL
not	NULL
Jak3	NULL
)	NULL
,	NULL
and	NULL
IL-2RB	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
SOCS-3	NULL
can	NULL
inhibit	NULL
Jak1	NULL
phosphorylation	NULL
,	NULL
that	NULL
this	NULL
is	NULL
accentuated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
IL-2RB	NULL
,	NULL
and	NULL
that	NULL
expression	NULL
of	NULL
SOCS-3	NULL
can	NULL
inhibit	NULL
IL-2	NULL
responses	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
anti-CIS	NULL
antiserum	NULL
was	NULL
previously	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
anti-SOCS-3	NULL
antiserum	NULL
was	NULL
generated	NULL
by	NULL
using	NULL
amino	NULL
acids	NULL
5	NULL
to	NULL
21	NULL
of	NULL
human	NULL
SOCS-3	NULL
protein	NULL
.	NULL

Anti-Myc	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
9E10	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
anti	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
FLAG	NULL
MAb	NULL
M2	NULL
was	NULL
purchased	NULL
from	NULL
Eastman	NULL
Kodak	NULL
(	NULL
Rochester	NULL
,	NULL
N.Y.	NULL
)	NULL
,	NULL
antiphosphotyrosine	NULL
MAb	NULL
4G10	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
anti-Jak3	NULL
and	NULL
anti-STAT5b	NULL
antisera	NULL
were	NULL
generous	NULL
gifts	NULL
of	NULL
J.	NULL
O'Shea	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
)	NULL
.	NULL

Jakl	NULL
MAb	NULL
was	NULL
obtained	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
Ky.	NULL
)	NULL
.	NULL

MAb	NULL
561	NULL
was	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
of	NULL
IL-2RB	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
;	NULL
antisera	NULL
to	NULL
IL-2RB	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
and	NULL
IL-3RB	NULL
,	NULL
,	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
were	NULL
used	NULL
for	NULL
Western	NULL
blotting	NULL
.	NULL

A	NULL
MAb	NULL
was	NULL
used	NULL
for	NULL
immunoblotting	NULL
Jak1	NULL
(	NULL
Trans-duction	NULL
Laboratories	NULL
)	NULL
.	NULL

Constructs	NULL
.	NULL

The	NULL
full-length	NULL
human	NULL
SOCS-3	NULL
and	NULL
SOCS-2	NULL
cDNAs	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
from	NULL
a	NULL
human	NULL
T-cell	NULL
library	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
mammalian	NULL
expression	NULL
vector	NULL
pME18S	NULL
(	NULL
in	NULL
which	NULL
expression	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
SRa	NULL
promoter	NULL
[	NULL
27	NULL
]	NULL
)	NULL
.	NULL

Human	NULL
recombinant	NULL
SOCS-3	NULL
(	NULL
hrSOCS-3	NULL
)	NULL
,	NULL
hrSOCS-2	NULL
,	NULL
murine	NULL
recombinant	NULL
Jak1	NULL
,	NULL
and	NULL
hrJak3	NULL
cDNA	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
and	NULL
subcloned	NULL
into	NULL
pME18S	NULL
with	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
FLAG	NULL
sequence	NULL
at	NULL
their	NULL
carboxy	NULL
termini	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IL-2RB	NULL
and	NULL
IL-2Ry	NULL
cDNAs	NULL
were	NULL
also	NULL
cloned	NULL
into	NULL
pME18S	NULL
.	NULL

A	NULL
previously	NULL
described	NULL
(	NULL
7	NULL
,	NULL
29	NULL
)	NULL
SOCS-1/JAB	NULL
construct	NULL
was	NULL
also	NULL
used	NULL
.	NULL

Cells	NULL
and	NULL
transfections	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
normal	NULL
donors	NULL
by	NULL
using	NULL
standard	NULL
protocols	NULL
and	NULL
stimulated	NULL
for	NULL
72	NULL
h	NULL
in	NULL
Yessel	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
human	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
and	NULL
100	NULL
U	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
mg	NULL
of	NULL
phytohemagglutinin	NULL
(	NULL
PHA-L	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

They	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
rested	NULL
for	NULL
12	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
human	NULL
serum	NULL
without	NULL
PHA	NULL
or	NULL
IL-2	NULL
.	NULL

YT	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
and	NULL
100	NULL
U	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
IL-2-dependent	NULL
T-cell	NULL
lines	NULL
HT-2	NULL
and	NULL
Kit-225	NULL
were	NULL
grown	NULL
as	NULL
described	NULL
above	NULL
in	NULL
medium	NULL
containing	NULL
50	NULL
U	NULL
of	NULL
IL-2	NULL
per	NULL
ml	NULL
.	NULL

Cytokine-dependent	NULL
cells	NULL
were	NULL
rested	NULL
in	NULL
RPMI	NULL
1640	NULL
medium-2	NULL
%	NULL
FBS	NULL
for	NULL
4	NULL
to	NULL
12	NULL
h	NULL
prior	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

BaF3	NULL
transfectants	NULL
(	NULL
maintained	NULL
in	NULL
IL-3	NULL
[	NULL
10	NULL
ng/ml	NULL
)	NULL
)	NULL
expressing	NULL
IL-2RB	NULL
and	NULL
SOCS-3	NULL
were	NULL
generated	NULL
by	NULL
electroporation	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
with	NULL
plasmids	NULL
containing	NULL
IL-2R	NULL
$	NULL
B	NULL
,	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
(	NULL
260	NULL
V	NULL
,	NULL
960	NULL
mF	NULL
)	NULL
,	NULL
and	NULL
were	NULL
selected	NULL
in	NULL
neomycin	NULL
(	NULL
2	NULL
mg/ml	NULL
;	NULL
Gibco	NULL
BRL	NULL
)	NULL
or	NULL
puromycin	NULL
(	NULL
200	NULL
pg/ml	NULL
;	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Resistant	NULL
clones	NULL
were	NULL
tested	NULL
for	NULL
IL-2RB	NULL
and	NULL
SOCS-3	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
IL-2RB	NULL
antiserum	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
or	NULL
antiserum	NULL
generated	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
SOCS-3	NULL
.	NULL

Ba/F3	NULL
cells	NULL
expressing	NULL
the	NULL
tetracycline-responsive	NULL
transcriptional	NULL
activator	NULL
protein	NULL
were	NULL
generated	NULL
by	NULL
electroporation	NULL
with	NULL
pUHD15-1	NULL
modified	NULL
to	NULL
contain	NULL
a	NULL
puromycin	NULL
resistance	NULL
gene	NULL
(	NULL
15	NULL
)	NULL
.	NULL

This	NULL
clone	NULL
was	NULL
transfected	NULL
with	NULL
pUHD10-3	NULL
containing	NULL
SOCS-3	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
above	NULL
and	NULL
selected	NULL
by	NULL
using	NULL
1.2	NULL
mg	NULL
of	NULL
hygromycin	NULL
per	NULL
ml	NULL
.	NULL

Tetracycline	NULL
(	NULL
1	NULL
g/ml	NULL
)	NULL
was	NULL
replaced	NULL
every	NULL
48	NULL
h	NULL
;	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
SOCS-3	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
for	NULL
36	NULL
h.	NULL
293T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
per	NULL
ml	NULL
and	NULL
transfected	NULL
at	NULL
40	NULL
to	NULL
50	NULL
%	NULL
confluency	NULL
,	NULL
using	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
reagents	NULL
by	NULL
standard	NULL
protocols	NULL
(	NULL
5'-3	NULL
'	NULL
,	NULL
Inc.	NULL
,	NULL
Boulder	NULL
,	NULL
Colo.	NULL
)	NULL
;	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
36	NULL
to	NULL
48	NULL
h.	NULL
To	NULL
test	NULL
cytokine	NULL
responses	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
IL-10	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
or	NULL
gamma	NULL
interferon	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
Northern	NULL
blot	NULL
analyses	NULL
.	NULL

Using	NULL
an	NULL
RNeasy	NULL
midi	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Valencia	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
we	NULL
extracted	NULL
total	NULL
RNA	NULL
from	NULL
PBL	NULL
s	NULL
or	NULL
cell	NULL
lines	NULL
either	NULL
treated	NULL
with	NULL
cytokine	NULL
or	NULL
untreated	NULL
and	NULL
quantitated	NULL
RNA	NULL
by	NULL
spectrophotometry	NULL
.	NULL

Then	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
overnight	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
formaldehyde	NULL
gel	NULL
.	NULL

Gels	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
water	NULL
and	NULL
then	NULL
denatured	NULL
for	NULL
30	NULL
min	NULL
in	NULL
50	NULL
mM	NULL
NaOH-10	NULL
mM	NULL
NaCl	NULL
,	NULL
rinsed	NULL
with	NULL
100	NULL
mM	NULL
Tris	NULL
HCI	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
finally	NULL
placed	NULL
in	NULL
10	NULL
%	NULL
SSC	NULL
(	NULL
1x	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Gels	NULL
were	NULL
transferred	NULL
overnight	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schleicher	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
.	NULL
)	NULL

that	NULL
had	NULL
been	NULL
pretreated	NULL
with	NULL
water	NULL
and	NULL
then	NULL
10	NULL
%	NULL
SSC	NULL
.	NULL

Following	NULL
transfer	NULL
,	NULL
membranes	NULL
were	NULL
rinsed	NULL
with	NULL
2	NULL
%	NULL
SSC	NULL
and	NULL
cross-linked	NULL
in	NULL
a	NULL
UV	NULL
Stratalinker	NULL
2400	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
Rapid-hyb	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
III	NULL
.	NULL
)	NULL

and	NULL
then	NULL
hybridized	NULL
with	NULL
cDNAs	NULL
labeled	NULL
by	NULL
random	NULL
priming	NULL
using	NULL
the	NULL
Rediprime	NULL
DNA	NULL
labeling	NULL
system	NULL
(	NULL
Amer-sham	NULL
)	NULL
.	NULL

Following	NULL
hybridization	NULL
,	NULL
membranes	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
final	NULL
wash	NULL
in	NULL
0.1	NULL
%	NULL
SSC-0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
at	NULL
65°C	NULL
.	NULL

Immunoprecipitations	NULL
and	NULL
immunoblotting	NULL
.	NULL

Following	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
lysed	NULL
in	NULL
Brij	NULL
97	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mg	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
aprotonin	NULL
per	NULL
m1	NULL
)	NULL
,	NULL
and	NULL
centrifuged	NULL
at	NULL
18,000	NULL
X	NULL
g	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Lysates	NULL
were	NULL
immunoblotted	NULL
as	NULL
described	NULL
below	NULL
or	NULL
immunoprecipitated	NULL
by	NULL
incubating	NULL
with	NULL
one	NULL
of	NULL
the	NULL
antibodies	NULL
described	NULL
above	NULL
bound	NULL
to	NULL
protein	NULL
A-agarose	NULL
beads	NULL
or	NULL
with	NULL
a	NULL
SOCS-3-glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
protein	NULL
bound	NULL
to	NULL
glutathione-Sepharose	NULL
,	NULL
for	NULL
2	NULL
to	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Lysates	NULL
and	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
,	NULL
boiled	NULL
in	NULL
reducing	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
resolved	NULL
on	NULL
SDS-polyacrylamide	NULL
gels	NULL
(	NULL
Novex	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
and	NULL
transferred	NULL
onto	NULL
Im-mobilon	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

Immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
antibodies	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
blots	NULL
were	NULL
visualized	NULL
by	NULL
enhanced	NULL
chemilumines-cence	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
III	NULL
.	NULL
)	NULL

.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
.	NULL

Following	NULL
immunoprecipitation	NULL
as	NULL
described	NULL
above	NULL
,	NULL
precipitates	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
MSH	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
kinase	NULL
reaction	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
MnCl	NULL
,	NULL
1	NULL
wM	NULL
ATP	NULL
)	NULL
containing	NULL
10	NULL
wCi	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
with	NULL
MSH	NULL
buffer	NULL
,	NULL
samples	NULL
were	NULL
boiled	NULL
in	NULL
THE	NULL
SOCS-3	NULL
PHOSPHOPROTEIN	NULL
REGULATES	NULL
IL-2	NULL
RESPONSES	NULL
-	NULL
4981	NULL
reducing	NULL
SDS	NULL
buffer	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
and	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Thymidine	NULL
incorporation	NULL
assay	NULL
.	NULL

Cells	NULL
from	NULL
two	NULL
BaF3	NULL
clones	NULL
inducibly	NULL
expressing	NULL
SOCS-3	NULL
were	NULL
rested	NULL
in	NULL
cytokine-free	NULL
medium	NULL
as	NULL
described	NULL
above	NULL
,	NULL
with	NULL
half	NULL
the	NULL
cells	NULL
first	NULL
being	NULL
removed	NULL
from	NULL
tetracycline	NULL
for	NULL
24	NULL
h.	NULL
Cells	NULL
(	NULL
4	NULL
x	NULL
10°	NULL
per	NULL
well	NULL
)	NULL
were	NULL
plated	NULL
in	NULL
a	NULL
96-well	NULL
plate	NULL
in	NULL
RPMI	NULL
1640	NULL
medium-5	NULL
%	NULL
FBS	NULL
,	NULL
with	NULL
or	NULL
without	NULL
tetracycline	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
and	NULL
with	NULL
no	NULL
cytokine	NULL
or	NULL
50	NULL
U	NULL
of	NULL
IL-2	NULL
per	NULL
ml	NULL
.	NULL

After	NULL
20	NULL
h	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
(	NULL
1	NULL
mCi/ml	NULL
)	NULL
was	NULL
added	NULL
for	NULL
4	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
onto	NULL
glass	NULL
fiber	NULL
filters	NULL
,	NULL
and	NULL
incorporated	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
was	NULL
quantitated	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
15	NULL
)	NULL
.	NULL

RESULTS	NULL
SOCS-3	NULL
and	NULL
CIS	NULL
are	NULL
rapidly	NULL
induced	NULL
by	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
SOCS	NULL
proteins	NULL
in	NULL
lymphocytes	NULL
,	NULL
we	NULL
initially	NULL
examined	NULL
their	NULL
expression	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Probing	NULL
of	NULL
multitissue	NULL
mRNA	NULL
blots	NULL
revealed	NULL
strong	NULL
expression	NULL
of	NULL
CIS	NULL
in	NULL
a	NULL
number	NULL
of	NULL
tissues	NULL
,	NULL
including	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
pros-tate	NULL
,	NULL
and	NULL
PBLs	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

While	NULL
SOCS-4	NULL
mRNA	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
PBLs	NULL
or	NULL
the	NULL
thymus	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
colon	NULL
.	NULL

Interestingly	NULL
,	NULL
although	NULL
SOCS-3	NULL
expression	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
spleen	NULL
,	NULL
highest	NULL
levels	NULL
were	NULL
seen	NULL
in	NULL
PBLs	NULL
,	NULL
with	NULL
lower	NULL
levels	NULL
detected	NULL
in	NULL
other	NULL
tissues	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
more	NULL
selective	NULL
expression	NULL
of	NULL
SOCS-3	NULL
in	NULL
comparison	NULL
to	NULL
other	NULL
SOCS	NULL
proteins	NULL
suggests	NULL
an	NULL
important	NULL
role	NULL
in	NULL
leukocytes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
SOCS	NULL
proteins	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
highly	NULL
regulated	NULL
by	NULL
cytokines	NULL
(	NULL
7	NULL
,	NULL
10	NULL
,	NULL
17	NULL
,	NULL
26	NULL
)	NULL
.	NULL

To	NULL
further	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
SOCS-3	NULL
and	NULL
CIS	NULL
proteins	NULL
in	NULL
lymphocytes	NULL
,	NULL
Kit-225	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
cytokine-free	NULL
,	NULL
reduced-serum	NULL
conditions	NULL
for	NULL
12	NULL
h	NULL
before	NULL
treatment	NULL
with	NULL
IL-2	NULL
for	NULL
periods	NULL
of	NULL
up	NULL
to	NULL
24	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
,	NULL
and	NULL
SOCS-3	NULL
and	NULL
CIS	NULL
were	NULL
immunoprecipitated	NULL
for	NULL
Western	NULL
blotting	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
SOCS-3	NULL
protein	NULL
was	NULL
detected	NULL
within	NULL
30	NULL
min	NULL
of	NULL
IL-2	NULL
stimulation	NULL
,	NULL
peaked	NULL
at	NULL
2	NULL
to	NULL
4	NULL
h	NULL
,	NULL
and	NULL
returned	NULL
to	NULL
basal	NULL
levels	NULL
within	NULL
8	NULL
h	NULL
;	NULL
CIS	NULL
was	NULL
first	NULL
seen	NULL
at	NULL
2	NULL
h	NULL
,	NULL
was	NULL
strongly	NULL
expressed	NULL
between	NULL
4	NULL
and	NULL
12	NULL
h	NULL
,	NULL
and	NULL
was	NULL
again	NULL
undetectable	NULL
at	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
observed	NULL
only	NULL
the	NULL
37-kDa	NULL
form	NULL
of	NULL
CIS	NULL
in	NULL
Kit-225	NULL
cells	NULL
,	NULL
although	NULL
32-	NULL
,	NULL
37-	NULL
,	NULL
and	NULL
45-kDa	NULL
forms	NULL
of	NULL
this	NULL
protein	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
13	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
the	NULL
YT	NULL
NK-like	NULL
cell	NULL
line	NULL
,	NULL
SOCS-3	NULL
expression	NULL
peaked	NULL
between	NULL
2	NULL
and	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
;	NULL
in	NULL
human	NULL
PBL-derived	NULL
blasts	NULL
,	NULL
SOCS-3	NULL
expression	NULL
was	NULL
noted	NULL
within	NULL
30	NULL
min	NULL
of	NULL
IL-2	NULL
stimulation	NULL
,	NULL
peaked	NULL
at	NULL
1	NULL
h	NULL
,	NULL
and	NULL
declined	NULL
thereafter	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Alpha	NULL
interferon	NULL
was	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
low	NULL
levels	NULL
of	NULL
SOCS-3	NULL
protein	NULL
expression	NULL
in	NULL
Kit-225	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
SOCS-3	NULL
protein	NULL
could	NULL
be	NULL
induced	NULL
by	NULL
other	NULL
cytokines	NULL
in	NULL
lymphocytes	NULL
,	NULL
IL-3-responsive	NULL
BaF3	NULL
cells	NULL
were	NULL
examined	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
cytokine-free	NULL
,	NULL
reduced-serum	NULL
medium	NULL
for	NULL
12	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
IL-3	NULL
.	NULL

SOCS-3	NULL
protein	NULL
was	NULL
initially	NULL
seen	NULL
at	NULL
30	NULL
min	NULL
,	NULL
peaked	NULL
at	NULL
1	NULL
h	NULL
,	NULL
and	NULL
was	NULL
absent	NULL
by	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
SOCS-3	NULL
is	NULL
a	NULL
short-lived	NULL
immediate-early	NULL
gene	NULL
product	NULL
,	NULL
induced	NULL
by	NULL
IL-2	NULL
,	NULL
and	NULL
IL-3	NULL
in	NULL
lymphocytes	NULL
.	NULL

SOCS-3	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

SOCS-1/JAB/SSI-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
Jak2	NULL
and	NULL
inhibit	NULL
its	NULL
activity	NULL
(	NULL
7	NULL
,	NULL
17	NULL
,	NULL
26	NULL
)	NULL
,	NULL
while	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
SOCS-3	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
Jak2-JH1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
whether	NULL
SOCS	NULL
proteins	NULL
themselves	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
whether	NULL
SOCS-3	NULL
may	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Again	NULL
Kit-225	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
following	NULL
12	NULL
h	NULL
in	NULL
cytokine-free	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
at	NULL
various	NULL
intervals	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
to	NULL
SOCS-3	NULL
,	NULL
and	NULL
immunoblotted	NULL
(	NULL
for	NULL
SOCS-3	NULL
expression	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
was	NULL
observed	NULL
at	NULL
30	NULL
min	NULL
and	NULL
was	NULL
maximal	NULL
between	NULL
1	NULL
and	NULL
2	NULL
h	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
SOCS-3	NULL
protein	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Phosphorylation	NULL
decreased	NULL
to	NULL
unde-	NULL
4982	NULL
,	NULL
COHNEY	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro	NULL
.	NULL

2	NULL
«	NULL
A	NULL
3	NULL
B	NULL
0	NULL
30°	NULL
ih	NULL
2h	NULL
4h	NULL
Sh	NULL
12h	NULL
24h	NULL
IP	NULL
:	NULL
o	NULL
CIS	NULL
@	NULL
9	NULL
50	NULL
-	NULL
~-	NULL
a	NULL
Blot	NULL
:	NULL
«	NULL
CIS	NULL
50	NULL
3	NULL
'	NULL
c	NULL
&	NULL
=	NULL
3	NULL
36	NULL
-	NULL
<	NULL
u	NULL
cue	NULL
cip	NULL
«	NULL
4-	NULL
CIS	NULL
o	NULL
a	NULL
9	NULL
c	NULL
a	NULL
0	NULL
30	NULL
~	NULL
9	NULL
2	NULL
2	NULL
3	NULL
o	NULL
IP	NULL
:	NULL
«	NULL
SOCS-3	NULL
a	NULL
€	NULL
E	NULL
E	NULL
5	NULL
so	NULL
5	NULL
2	NULL
§	NULL
o	NULL
>	NULL
=	NULL
<	NULL
5	NULL
-	NULL
Blot	NULL
:	NULL
o.	NULL
SOCS-3	NULL
0	NULL
E	NULL
b	NULL
sL	NULL
T	NULL
5	NULL
a	NULL
a	NULL
2	NULL
9	NULL
2G	NULL
3	NULL
a	NULL
£	NULL
a	NULL
25	NULL
§	NULL
g	NULL
g	NULL
36	NULL
30	NULL
_-	NULL
coats	NULL
tts	NULL
o	NULL
»	NULL
``	NULL
ste	NULL
+4	NULL
«	NULL
g-	NULL
SocS-3	NULL
we	NULL
-	NULL
wn	NULL
wi	NULL
wi	NULL
an	NULL
th	NULL
-SOCS-4	NULL
D	NULL
ss	NULL
-	NULL
pq	NULL
L	NULL
a	NULL
-	NULL
«	NULL
-	NULL
SOcS-3	NULL
30	NULL
n	NULL
...	NULL
‘	NULL
l	NULL
0	NULL
30	NULL
'	NULL
ih	NULL
2h	NULL
3h	NULL
4h	NULL
'	NULL
.	NULL
``	NULL

O	NULL
”	NULL
-CIS	NULL
w	NULL
_	NULL
-socs-s	NULL
m	NULL
AEO	NULL
BB	NULL
_	NULL
-actin	NULL
C	NULL
-	NULL
KIT-225	NULL
36	NULL
30	NULL
-	NULL
IRI	NULL
wo	NULL
<	NULL
-	NULL
socs-s	NULL
0	NULL
1th	NULL
2h	NULL
4h	NULL
Sh	NULL
a	NULL
PBL	NULL
36	NULL
-	NULL
36	NULL
__	NULL
%	NULL
%	NULL
_	NULL
«	NULL
-	NULL
SocsS-3	NULL
ao	NULL
-	NULL
~~	NULL
BDRM	NULL
.	NULL

<	NULL
-	NULL
socs-s	NULL
®	NULL
m	NULL
0	NULL
th	NULL
2h	NULL
4h	NULL
Sh	NULL
0	NULL
30°	NULL
ih	NULL
2h	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

SOCS-3	NULL
is	NULL
expressed	NULL
in	NULL
lymphocytes	NULL
and	NULL
regulated	NULL
by	NULL
IL-2	NULL
and	NULL
IL-3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tissue	NULL
mRNA	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
cDNAs	NULL
to	NULL
CIS	NULL
,	NULL
SOCS-3	NULL
,	NULL
and	NULL
SOCS-4	NULL
,	NULL
with	NULL
B-actin	NULL
as	NULL
a	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Kit-225	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
antiserum	NULL
to	NULL
either	NULL
SOCS-3	NULL
(	NULL
«	NULL
SOCS	NULL
$	NULL
3	NULL
)	NULL
or	NULL
CIS	NULL
(	NULL
aCIS	NULL
)	NULL
prior	NULL
to	NULL
SDS-PAGE	NULL
.	NULL

Filters	NULL
were	NULL
blotted	NULL
with	NULL
the	NULL
corresponding	NULL
antibody	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Kit-225	NULL
cells	NULL
,	NULL
YT	NULL
cells	NULL
,	NULL
or	NULL
PHA	NULL
blasts	NULL
were	NULL
rested	NULL
overnight	NULL
in	NULL
2	NULL
%	NULL
FBS	NULL
,	NULL
stimulated	NULL
with	NULL
IL-2	NULL
for	NULL
between	NULL
30	NULL
min	NULL
and	NULL
8	NULL
h	NULL
,	NULL
lysed	NULL
,	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
antiserum	NULL
to	NULL
SOCS-3	NULL
.	NULL

(	NULL
D	NULL
)	NULL
BaF3	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
cytokine-free	NULL
medium	NULL
overnight	NULL
and	NULL
treated	NULL
with	NULL
IL-3	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
immunoblotted	NULL
with	NULL
antiserum	NULL
to	NULL
SOCS-3	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

tectable	NULL
levels	NULL
within	NULL
4	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
although	NULL
IL-4	NULL
also	NULL
signals	NULL
through	NULL
y	NULL
,	NULL
,	NULL
and	NULL
activates	NULL
the	NULL
same	NULL
Jak	NULL
kinases	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
induction	NULL
of	NULL
SOCS-3	NULL
protein	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
at	NULL
1	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
despite	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
SOCS-3	NULL
induced	NULL
by	NULL
IL-3	NULL
in	NULL
BaF3	NULL
cells	NULL
,	NULL
no	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
seen	NULL
in	NULL
four	NULL
experiments	NULL
.	NULL

Consistent	NULL
with	NULL
previously	NULL
published	NULL
results	NULL
(	NULL
7	NULL
)	NULL
,	NULL
no	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CIS	NULL
was	NULL
seen	NULL
following	NULL
its	NULL
induction	NULL
by	NULL
IL-2	NULL
or	NULL
IL-3	NULL
.	NULL

SOCS-3	NULL
associates	NULL
with	NULL
and	NULL
is	NULL
phosphorylated	NULL
by	NULL
Jak1	NULL
.	NULL

The	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
suggests	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
an	NULL
IL-2-activated	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
its	NULL
possible	NULL
interaction	NULL
with	NULL
the	NULL
IL-Z-activated	NULL
Jak	NULL
kinases	NULL
,	NULL
Jak1	NULL
and	NULL
Jak3	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
cDNA	NULL
encoding	NULL
SOCS-3	NULL
,	NULL
Jak1	NULL
,	NULL
Jak3	NULL
,	NULL
or	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
directed	NULL
against	NULL
SOCS-3	NULL
.	NULL

Jak1	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
SOCS-3	NULL
immunoprecipitates	NULL
in	NULL
cells	NULL
expressing	NULL
Jak	NULL
]	NULL
or	NULL
expressing	NULL
Jak1	NULL
and	NULL
IL-2RB	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
first	NULL
and	NULL
third	NULL
panels	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
high	NULL
levels	NULL
of	NULL
Jak3	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
coprecipitation	NULL
of	NULL
Jak3	NULL
with	NULL
SOCS-3	NULL
was	NULL
not	NULL
detected	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

SOCS-3	NULL
was	NULL
strongly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Jak1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
third	NULL
panel	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
but	NULL
only	NULL
weakly	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Jak3	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
SOCS-3	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
coexpressed	NULL
with	NULL
Lek	NULL
and	NULL
Jak2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
interaction	NULL
observed	NULL
between	NULL
Jak1	NULL
and	NULL
SOCS-3	NULL
suggest	NULL
that	NULL
Jakl	NULL
could	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
IL-2-induced	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
observed	NULL
in	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

SOCS-3	NULL
inhibits	NULL
Jakl	NULL
but	NULL
not	NULL
Jak3	NULL
phosphorylation	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
is	NULL
maximal	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2RB	NULL
.	NULL

As	NULL
SOCS-1	NULL
inhibits	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak	NULL
kinases	NULL
,	NULL
and	NULL
in	NULL
view	NULL
of	NULL
our	NULL
findings	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
SOCS-3	NULL
would	NULL
inhibit	NULL
Jak1	NULL
or	NULL
Jak3	NULL
phosphorylation	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
293T	NULL
cells	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
kDa	NULL
36	NULL
30	NULL
36	NULL
30	NULL
C	NULL
Jaki	NULL
socs-1	NULL
socs-2	NULL
socs-s	NULL
IL-2R8	NULL
THE	NULL
SOCS-3	NULL
PHOSPHOPROTEIN	NULL
REGULATES	NULL
IL-2	NULL
RESPONSES	NULL
4983	NULL
Whole	NULL
Cell	NULL
Lysate	NULL
IL2	NULL
IL4	NULL
IP	NULL
:	NULL
SOCS-3	NULL
1018-30	NULL
Bh	NULL
imm	NULL
]	NULL
IP	NULL
:	NULL
e	NULL
«	NULL
SOCS-3	NULL
Blot	NULL
:	NULL
«	NULL
PTyr	NULL
B	NULL
kDa	NULL
250	NULL
-	NULL
yom	NULL
Blot	NULL
:	NULL
aPTyr	NULL
Me	NULL
Ad	NULL
alee	NULL
.	NULL

wes	NULL
+	NULL
z	NULL
«	NULL
g-	NULL
Jak	NULL
1	NULL
z	NULL
Jak	NULL
3	NULL
Blot	NULL
:	NULL
«	NULL
SOCS-3	NULL
Oth	NULL
toll	NULL
hun	NULL
-	NULL
wth	NULL
outs	NULL
coum	NULL
«	NULL
--	NULL
a	NULL
@	NULL
t	NULL
98	NULL
-	NULL
bo	NULL
cues	NULL
cuits	NULL
.	NULL

<	NULL
-	NULL
1-298	NULL
20s	NULL
40	NULL
506	NULL
64	NULL
mee	NULL
@	NULL
UJ	NULL
#	NULL
#	NULL
es	NULL
Pi	NULL
-4-	NULL
socs-3	NULL
30	NULL
-	NULL
®	NULL
1	NULL
2	NULL
$	NULL
Blot	NULL
:	NULL
aJak1/Jak3	NULL
woth	NULL
whith	NULL
.	NULL

«	NULL
g-	NULL
Jak	NULL
1	NULL
“	NULL
It	NULL
«	NULL
g-	NULL
Jak	NULL
3	NULL
_	NULL
_	NULL
Blot	NULL
:	NULL
aSOCS-3	NULL
XU	NULL
(	NULL
A	NULL
%	NULL
--	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Jak1	NULL
+	NULL
0+	NULL
+	NULL
-o	NULL
>	NULL
>	NULL
Jak3	NULL
kok	NULL
k	NULL
g	NULL
£	NULL
&	NULL
IL2RB	NULL
-o	NULL
n	NULL
+	NULL
to	NULL
n	NULL
+	NULL
sOC§-3	NULL
-	NULL
+	NULL
+	NULL
-o	NULL
+	NULL
O+	NULL
Whole	NULL
Cell	NULL
Lysates	NULL
Whole	NULL
Cell	NULL
Lysates	NULL
1	NULL
z	NULL
a	NULL
i	NULL
8	NULL
a	NULL
9	NULL
%	NULL
Blot	NULL
:	NULL
«	NULL
PTyr	NULL
sq	NULL
Do	NULL
1	NULL
2	NULL
s	NULL
4	NULL
5060	NULL
T	NULL
s	NULL
a	NULL
Blot	NULL
:	NULL
«	NULL
PTyr	NULL
#	NULL
(	NULL
#	NULL
n	NULL
!	NULL

.	NULL

!	NULL

;	NULL
q	NULL
«	NULL
g-	NULL
Jak	NULL
3	NULL
’	NULL
a	NULL
a	NULL
a	NULL
...	NULL
mM	NULL
P	NULL
m	NULL
8	NULL
*	NULL
ag-	NULL
IL4BB	NULL
Blot	NULL
:	NULL
wim	NULL
``	NULL
<	NULL
g-	NULL
IL-2R8	NULL
Blot	NULL
:	NULL
aJak1	NULL
UB	NULL
«	NULL
»	NULL
an	NULL
an	NULL
ae	NULL
#	NULL
6	NULL
WD	NULL
«	NULL
-	NULL
ci	NULL
IP	NULL
:	NULL
«	NULL
Flag	NULL
Blot	NULL
:	NULL
«	NULL
Flag	NULL
Blot	NULL
:	NULL
olL-2R	NULL
&	NULL
i	NULL
B	NULL
Ub	NULL
un	NULL
-	NULL
as	NULL
--	NULL
<	NULL
-	NULL
.s	NULL
)	NULL
<	NULL
-	NULL
sue	NULL
os	NULL
cus	NULL
--	NULL
ass	NULL
cus	NULL
o	NULL
cie	NULL
~~~	NULL
IP	NULL
:	NULL
oFlag	NULL
v	NULL
Blot	NULL
:	NULL
oFlag	NULL
«	NULL
g-	NULL
SOcS-3	NULL
H	NULL
«	NULL
-Ss0cS-3	NULL
Se	NULL
‘	NULL
.—-	NULL
-.-—	NULL
«	NULL
-	NULL
socs-2	NULL
``	NULL
e®	NULL
!	NULL

l4__s0Cs-2	NULL
IP	NULL
:	NULL
omyc	NULL
Blot	NULL
:	NULL
omyc	NULL
Jak3	NULL
+o	NULL
to	NULL
¢	NULL
b	NULL
4	NULL
o	NULL
$	NULL
goog	NULL
o+	NULL
%	NULL
WB	NULL
<	NULL
-	NULL
socs-1	NULL
SsOC§-2	NULL
-	NULL
&	NULL
-	NULL
>	NULL
+	NULL
>	NULL
+00-sOC§-3	NULL
-	NULL
~	NULL
&	NULL
~	NULL
>	NULL
+	NULL
-o	NULL
+	NULL
%	NULL
%	NULL
+	NULL
%	NULL
%	NULL
tog	NULL
#	NULL
IL-2RB	NULL
-	NULL
>	NULL
o	NULL
>	NULL
4	NULL
+	NULL
+	NULL
e	NULL
``	NULL
so	NULL
€	NULL
c	NULL
#	NULL
go	NULL
%	NULL
IL-2Ry	NULL
>	NULL
>	NULL
>	NULL
>	NULL
n	NULL
n	NULL
4+	NULL
400	NULL
%	NULL
sow	NULL
z	NULL
owo	NULL
omo	NULL
%	NULL
o	NULL
%	NULL
o	NULL
a	NULL
e	NULL
no	NULL
>	NULL
n	NULL
40	NULL
40	NULL
#	NULL
of	NULL
Blot	NULL
:	NULL
aJak1/Jak3	NULL
<	NULL
-	NULL
Jak	NULL
1	NULL
Wet	NULL
(	NULL
@	NULL
i	NULL
_	NULL
a-	NULL
Jaks	NULL
Blot	NULL
:	NULL
«	NULL
lL-2Rf	NULL
l	NULL
«	NULL
g-	NULL
IL-2R8	NULL
5	NULL
06	NULL
4	NULL
IVK	NULL
so	NULL
-	NULL
IP	NULL
:	NULL
oFlag	NULL
36	NULL
o	NULL
CJ	NULL
<	NULL
-	NULL
socs-3	NULL
TT	NULL
Blot	NULL
:	NULL
a	NULL
Jaki	NULL
<	NULL
-	NULL
Jak	NULL
1	NULL
Whole	NULL
Cell	NULL
Lysate	NULL
Blot	NULL
:	NULL
o	NULL
IL-2RB	NULL
©	NULL
-	NULL
#	NULL
-	NULL
>	NULL
»	NULL
=	NULL
Blot	NULL
:	NULL
o	NULL
Flag	NULL
am	NULL
aem	NULL
<	NULL
-	NULL
SOCS-3	NULL
ue	NULL
<	NULL
-	NULL
SOCS-2	NULL
1	NULL
23	NULL
4	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
in	NULL
lymphocytes	NULL
treated	NULL
with	NULL
IL-2	NULL
and	NULL
by	NULL
Jak1	NULL
in	NULL
293	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Kit-225	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
antiserum	NULL
to	NULL
SOCS-3	NULL
(	NULL
aSOCS-3	NULL
)	NULL
.	NULL

Immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
same	NULL
antibody	NULL
or	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
aPTyr	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
293	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Jak1	NULL
or	NULL
Jak3	NULL
in	NULL
combination	NULL
with	NULL
SOCS-3	NULL
and	NULL
IL-2RB	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
with	NULL
antiserum	NULL
to	NULL
SOCS-3	NULL
.	NULL

Immunoprecipitates	NULL
and	NULL
whole-cell	NULL
lysates	NULL
were	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
or	NULL
antiserum	NULL
to	NULL
SOCS-3	NULL
,	NULL
Jak1	NULL
,	NULL
or	NULL
Jak3	NULL
.	NULL

Expression	NULL
levels	NULL
of	NULL
Jak	NULL
kinases	NULL
and	NULL
IL-2RB	NULL
were	NULL
tested	NULL
on	NULL
whole-cell	NULL
lysates	NULL
.	NULL

(	NULL
C	NULL
)	NULL
293	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
plasmids	NULL
containing	NULL
DNA	NULL
encoding	NULL
Jak1	NULL
,	NULL
IL-2RB	NULL
,	NULL
SOCS-1	NULL
,	NULL
SOCS-2	NULL
,	NULL
and	NULL
SOCS-3	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
whole-cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Blots	NULL
were	NULL
reprobed	NULL
to	NULL
check	NULL
expression	NULL
levels	NULL
.	NULL

(	NULL
D	NULL
)	NULL
293	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
plasmids	NULL
encoding	NULL
Jak3	NULL
,	NULL
IL-2RB	NULL
,	NULL
SOCS-1	NULL
,	NULL
SOCS-2	NULL
,	NULL
and	NULL
SOCS-3	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

(	NULL
E	NULL
)	NULL
293	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
Jak1	NULL
(	NULL
all	NULL
lanes	NULL
)	NULL
,	NULL
IL-2RB	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
SOCS-2	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
SOCS-3	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
;	NULL
the	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
MAb	NULL
M2	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
kinase	NULL
(	NULL
IVK	NULL
)	NULL
assays	NULL
performed	NULL
on	NULL
FLAG-tagged	NULL
Jak1	NULL
and	NULL
SOCS	NULL
proteins	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

4984	NULL
COHNEY	NULL
ET	NULL
AL	NULL
.	NULL

Preclear	NULL
A	NULL
IL-2R	NULL
$	NULL
B	NULL
+	NULL
GST-	NULL
GST-	NULL
IP	NULL
_	NULL
GST-	NULL
$	NULL
0OCS-3	NULL
PLCy	NULL
IL-2RBSOCS-3	NULL
IL-2	NULL
0	NULL
m-pm-	NULL
@	NULL
r-	NULL
-i-	NULL
250-	NULL
'	NULL
Blot	NULL
:	NULL
(	NULL
XPTyr	NULL
Lad	NULL
mi	NULL
*	NULL
M	NULL
'	NULL
«	NULL
g-Jaki	NULL
as	NULL
‘	NULL
«	NULL
g-64a-	NULL
|	NULL
50	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ast-	NULL
__	NULL
ip	NULL
IL-2	NULL
m-	NULL
m-l_	NULL
We	NULL
Blot	NULL
:	NULL
eJak1	NULL
C	NULL
IL-2	NULL
min	NULL
-	NULL
[	NULL
0	NULL
15	NULL
301	NULL
ipusocs-s	NULL
200	NULL
-	NULL
Blot	NULL
:	NULL
wuss	NULL
.	NULL

<	NULL
G-JAK1	NULL
96	NULL
_	NULL
Blot	NULL
:	NULL
(	NULL
SOCS-3	NULL
dommes	NULL
deme	NULL
<	NULL
4	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

SOCS-3	NULL
associates	NULL
with	NULL
the	NULL
IL-2R	NULL
complex	NULL
following	NULL
IL-2	NULL
stimulation	NULL
of	NULL
lymphocytes	NULL
.	NULL

Kit-225	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
and	NULL
treated	NULL
with	NULL
IL-2	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cells	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
GST-SOCS-3	NULL
fusion	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
immunoprecipitates	NULL
(	NULL
IP	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
membrane	NULL
transfer	NULL
.	NULL

Filters	NULL
were	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
(	NULL
aPTyr	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
anti-Jak1	NULL
(	NULL
aJak1	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
BaF3	NULL
cells	NULL
expressing	NULL
both	NULL
IL-2RB	NULL
and	NULL
SOCS-3	NULL
were	NULL
treated	NULL
with	NULL
MG132	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
for	NULL
30	NULL
min	NULL
and	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
for	NULL
15	NULL
or	NULL
30	NULL
min	NULL
;	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
antiserum	NULL
to	NULL
SOCS3	NULL
and	NULL
blotted	NULL
for	NULL
Jak1	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
SOCS-3	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

were	NULL
transfected	NULL
with	NULL
cDNA	NULL
encoding	NULL
Jak1	NULL
or	NULL
Jak3	NULL
in	NULL
combination	NULL
with	NULL
receptor	NULL
component	NULL
IL-2RB	NULL
or	NULL
IL-2Ry	NULL
and	NULL
either	NULL
SsOCS-1	NULL
,	NULL
SOCS-2	NULL
,	NULL
or	NULL
SOCS-3	NULL
.	NULL

Coexpression	NULL
studies	NULL
consistently	NULL
revealed	NULL
that	NULL
SOCS-1	NULL
and	NULL
SOCS-3	NULL
inhibited	NULL
the	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
,	NULL
while	NULL
SOCS-2	NULL
did	NULL
not	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

is	NULL
known	NULL
to	NULL
associate	NULL
(	NULL
constitutively	NULL
)	NULL
with	NULL
Jak1	NULL
;	NULL
interestingly	NULL
,	NULL
the	NULL
SOCS-3-mediated	NULL
inhibition	NULL
of	NULL
Jak1	NULL
phosphorylation	NULL
was	NULL
strongly	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2RB	NULL
,	NULL
with	NULL
almost	NULL
complete	NULL
abolition	NULL
of	NULL
Jak1	NULL
tyrosine	NULL
phosphorylation	NULL
being	NULL
observed	NULL
(	NULL
lane	NULL
3	NULL
versus	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
the	NULL
previous	NULL
experiment	NULL
where	NULL
Jak1	NULL
and	NULL
SOCS-3	NULL
were	NULL
coimmunoprecipitated	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
both	NULL
Jak1	NULL
and	NULL
SOCS-3	NULL
was	NULL
significantly	NULL
reduced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL2RB	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previously	NULL
published	NULL
data	NULL
,	NULL
we	NULL
found	NULL
that	NULL
293T	NULL
cells	NULL
expressing	NULL
SOCS-1	NULL
showed	NULL
reduced	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
small	NULL
reduction	NULL
in	NULL
expression	NULL
of	NULL
Jak1	NULL
.	NULL

However	NULL
,	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
SOCS-1	NULL
on	NULL
Jak1	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
not	NULL
augmented	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
IL-2RB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Coexpression	NULL
of	NULL
SOCS-3	NULL
or	NULL
SOCS-2	NULL
with	NULL
Jak3	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
Jak3	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
and	NULL
this	NULL
was	NULL
not	NULL
influenced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
IL-2Rf	NULL
or	NULL
IL-2Ry	NULL
(	NULL
the	NULL
latter	NULL
which	NULL
is	NULL
known	NULL
to	NULL
associate	NULL
with	NULL
Jak3	NULL
)	NULL
;	NULL
interestingly	NULL
,	NULL
SOCS-1	NULL
also	NULL
did	NULL
not	NULL
inhibit	NULL
Jak3	NULL
autophosphorylation	NULL
when	NULL
coexpressed	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Once	NULL
again	NULL
,	NULL
no	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Jak3	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
findings	NULL
indicate	NULL
that	NULL
while	NULL
SOCS-3	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
Jak3	NULL
,	NULL
it	NULL
can	NULL
strongly	NULL
associate	NULL
with	NULL
Jak1	NULL
and	NULL
inhibit	NULL
its	NULL
phosphorylation	NULL
,	NULL
an	NULL
effect	NULL
that	NULL
is	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2RfB	NULL
.	NULL

SOCS-3	NULL
inhibits	NULL
Jakl	NULL
kinase	NULL
activity	NULL
.	NULL

Experiments	NULL
from	NULL
other	NULL
groups	NULL
have	NULL
shown	NULL
that	NULL
SOCS-1	NULL
not	NULL
only	NULL
inhibits	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Tyk2	NULL
but	NULL
also	NULL
can	NULL
inhibit	NULL
Jak	NULL
kinase	NULL
activity	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
Jak1	NULL
autophosphorylation	NULL
in	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
(	NULL
20a	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
failed	NULL
to	NULL
detect	NULL
any	NULL
inhibition	NULL
of	NULL
kinase	NULL
activity	NULL
by	NULL
SOCS-3	NULL
.	NULL

In	NULL
view	NULL
of	NULL
our	NULL
findings	NULL
demonstrating	NULL
an	NULL
enhanced	NULL
inhibitory	NULL
effect	NULL
of	NULL
SOCS-3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2RB	NULL
,	NULL
we	NULL
performed	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
using	NULL
293	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
FLAG-tagged	NULL
Jak1	NULL
and	NULL
SOCS	NULL
proteins	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-FLAG	NULL
antibody	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
IL-2RB	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL2RB	NULL
to	NULL
Jak1	NULL
and	NULL
SOCS-3	NULL
markedly	NULL
reduced	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
Jak1	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
ability	NULL
to	NULL
phosphorylate	NULL
SOCS-3	NULL
(	NULL
Fig	NULL
.	NULL

26	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

When	NULL
SOCS-2	NULL
was	NULL
expressed	NULL
with	NULL
Jak1	NULL
,	NULL
it	NULL
was	NULL
not	NULL
phosphorylated	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
kinase	NULL
reaction	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
SOCS-3	NULL
can	NULL
strongly	NULL
inhibit	NULL
Jak1	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2RfB	NULL
.	NULL

SOCS-3	NULL
associates	NULL
with	NULL
tyrosine-phosphorylated	NULL
Jakl	NULL
and	NULL
IL-2RfB	NULL
following	NULL
IL-2	NULL
stimulation	NULL
.	NULL

CIS	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
EPOR	NULL
and	NULL
IL-3RB	NULL
,	NULL
,	NULL
(	NULL
29	NULL
)	NULL
;	NULL
in	NULL
light	NULL
of	NULL
this	NULL
finding	NULL
and	NULL
the	NULL
interactions	NULL
demonstrated	NULL
above	NULL
between	NULL
SOCS-3	NULL
,	NULL
Jak1	NULL
,	NULL
and	NULL
IL-2R	NULL
$	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
SOCS-3	NULL
might	NULL
associate	NULL
with	NULL
the	NULL
IL-2R	NULL
complex	NULL
in	NULL
lymphocytes	NULL
.	NULL

We	NULL
therefore	NULL
generated	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
containing	NULL
full-length	NULL
SOCS-3	NULL
,	NULL
and	NULL
lysates	NULL
from	NULL
untreated	NULL
or	NULL
IL-2-stimulated	NULL
Kit-225	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
SOCS-3-GST	NULL
fusion	NULL
protein	NULL
or	NULL
a	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
phospholipase	NULL
Cy	NULL
(	NULL
PLCy	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
pull-down	NULL
products	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

Following	NULL
IL-2	NULL
treatment	NULL
,	NULL
GST-SOCS-3	NULL
coprecipitated	NULL
a	NULL
tyrosine-phosphorylated	NULL
protein	NULL
similar	NULL
in	NULL
molecular	NULL
weight	NULL
to	NULL
IL-2Rf	NULL
and	NULL
one	NULL
similar	NULL
in	NULL
size	NULL
to	NULL
tyrosine-phosphorylated	NULL
Jak1	NULL
(	NULL
~130	NULL
kDa	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
PLCy	NULL
did	NULL
not	NULL
precipitate	NULL
Jak1	NULL
but	NULL
coprecipitated	NULL
a	NULL
protein	NULL
of	NULL
120	NULL
kDa	NULL
,	NULL
perhaps	NULL
tyrosine-phosphorylated	NULL
PLCy	NULL
,	NULL
also	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
Kit-225	NULL
lysates	NULL
were	NULL
also	NULL
immunoprecipitated	NULL
with	NULL
antibody	NULL
specific	NULL
for	NULL
IL-Z2RB	NULL
;	NULL
in	NULL
these	NULL
lanes	NULL
we	NULL
could	NULL
detect	NULL
both	NULL
tyrosine-phosphorylated	NULL
IL-ZRB	NULL
chain	NULL
and	NULL
tyrosine	NULL
phosphorylated	NULL
Jak1	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
that	NULL
the	NULL
75-kDa	NULL
phosphoprotein	NULL
with	NULL
which	NULL
the	NULL
SOCS-3	NULL
fusion	NULL
protein	NULL
was	NULL
observed	NULL
to	NULL
interact	NULL
was	NULL
indeed	NULL
IL-2RfB	NULL
,	NULL
lysates	NULL
were	NULL
initially	NULL
precleared	NULL
by	NULL
using	NULL
IL-ZRB	NULL
antibody	NULL
before	NULL
pre-	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
cipitation	NULL
with	NULL
SOCS-3	NULL
fusion	NULL
protein	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
preclearing	NULL
with	NULL
antiserum	NULL
to	NULL
IL-2RB	NULL
almost	NULL
completely	NULL
removed	NULL
the	NULL
75-kDa	NULL
phosphoprotein	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
protein	NULL
was	NULL
IL-2R	NULL
$	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
SOCS-3	NULL
did	NULL
associate	NULL
with	NULL
tyrosine-phosphorylated	NULL
Jak1	NULL
following	NULL
IL-2	NULL
treatment	NULL
,	NULL
lysates	NULL
from	NULL
IL-2-stimulated	NULL
Kit-225	NULL
cells	NULL
were	NULL
precipitated	NULL
with	NULL
GST-SOCS-3	NULL
or	NULL
antiserum	NULL
to	NULL
IL-2RfB	NULL
then	NULL
and	NULL
immunoblotted	NULL
for	NULL
Jak1	NULL
.	NULL

While	NULL
the	NULL
IL-2	NULL
receptor	NULL
was	NULL
constitutively	NULL
associated	NULL
with	NULL
Jak1	NULL
,	NULL
coprecipitation	NULL
of	NULL
GST-SOCS-3	NULL
with	NULL
Jak1	NULL
was	NULL
observed	NULL
only	NULL
following	NULL
IL-2	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
in	NULL
lymphocytes	NULL
,	NULL
SOCS-3	NULL
can	NULL
physically	NULL
interact	NULL
with	NULL
Jak1	NULL
and	NULL
IL-ZRB	NULL
,	NULL
but	NULL
only	NULL
following	NULL
IL-2-induced	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
Jakl	NULL
could	NULL
associate	NULL
with	NULL
SOCS-3	NULL
following	NULL
IL-2	NULL
stimulation	NULL
by	NULL
using	NULL
BaF3	NULL
cells	NULL
expressing	NULL
SOCS-3	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

BaF3	NULL
cells	NULL
expressing	NULL
both	NULL
IL-Z2RB	NULL
and	NULL
SOCS-3	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
with	NULL
MG132	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
for	NULL
30	NULL
min	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
for	NULL
15	NULL
or	NULL
30	NULL
min	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antisera	NULL
to	NULL
SOCS-3	NULL
and	NULL
immunoblotted	NULL
with	NULL
Jak1	NULL
MAb	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
proteosome	NULL
inhibitor	NULL
MG132	NULL
,	NULL
we	NULL
observed	NULL
an	NULL
enhanced	NULL
association	NULL
of	NULL
SOCS-3	NULL
with	NULL
Jak1	NULL
following	NULL
IL-2	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
Jak1	NULL
can	NULL
associate	NULL
with	NULL
SOCS-3	NULL
and	NULL
implies	NULL
that	NULL
this	NULL
complex	NULL
may	NULL
normally	NULL
be	NULL
short-lived	NULL
.	NULL

SOCS-3	NULL
inhibits	NULL
IL-2-induced	NULL
STATS	NULL
activation	NULL
.	NULL

Both	NULL
CIS	NULL
and	NULL
SOCS-1	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
various	NULL
cytokine	NULL
responses	NULL
.	NULL

CIS	NULL
was	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
IL-3R	NULL
and	NULL
EPOR	NULL
and	NULL
to	NULL
inhibit	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
(	NULL
29	NULL
)	NULL
.	NULL

SOCS-1	NULL
was	NULL
reported	NULL
to	NULL
reduce	NULL
IL-6	NULL
and	NULL
LIF	NULL
responses	NULL
by	NULL
binding	NULL
to	NULL
Jak2	NULL
(	NULL
7	NULL
,	NULL
17	NULL
,	NULL
26	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
SOCS-3	NULL
on	NULL
IL-2-	NULL
and	NULL
IL-3-induced	NULL
STATS	NULL
phosphorylation	NULL
.	NULL

We	NULL
established	NULL
clones	NULL
in	NULL
which	NULL
SOCS-3	NULL
expression	NULL
is	NULL
suppressed	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
23	NULL
)	NULL
.	NULL

BaF3	NULL
cells	NULL
containing	NULL
both	NULL
tetracycline-responsive	NULL
transcriptional	NULL
activator	NULL
and	NULL
IL-2RB	NULL
were	NULL
created	NULL
,	NULL
following	NULL
which	NULL
SOCS-3	NULL
was	NULL
introduced	NULL
in	NULL
the	NULL
pUHD10-3	NULL
vector	NULL
,	NULL
such	NULL
that	NULL
expression	NULL
of	NULL
SOCS-3	NULL
was	NULL
induced	NULL
by	NULL
removing	NULL
the	NULL
cells	NULL
from	NULL
tetracycline	NULL
.	NULL

At	NULL
36	NULL
h	NULL
after	NULL
removal	NULL
from	NULL
tetracycline	NULL
,	NULL
including	NULL
a	NULL
12-h	NULL
period	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytokine	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
IL-2	NULL
or	NULL
IL-3	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
levels	NULL
of	NULL
tyrosine-phosphorylated	NULL
STAT	NULL
5b	NULL
and	NULL
IL-Z2RB	NULL
were	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
cells	NULL
maintained	NULL
in	NULL
tetracycline	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
cells	NULL
removed	NULL
from	NULL
tetracycline	NULL
for	NULL
36	NULL
h	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
SOCS-3	NULL
in	NULL
comparison	NULL
to	NULL
cells	NULL
maintained	NULL
in	NULL
tetracycline	NULL
.	NULL

IL-2-	NULL
and	NULL
IL-3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5b	NULL
was	NULL
seen	NULL
in	NULL
cells	NULL
not	NULL
expressing	NULL
SOCS-3	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
11	NULL
,	NULL
and	NULL
12	NULL
)	NULL
;	NULL
however	NULL
,	NULL
in	NULL
cells	NULL
removed	NULL
from	NULL
tetracycline	NULL
(	NULL
which	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
SOCS-3	NULL
)	NULL
,	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
detectable	NULL
STATS5b	NULL
phosphorylation	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
(	NULL
lane	NULL
2	NULL
compared	NULL
to	NULL
lane	NULL
5	NULL
;	NULL
lane	NULL
8	NULL
compared	NULL
to	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
while	NULL
there	NULL
was	NULL
only	NULL
a	NULL
marginal	NULL
reduction	NULL
in	NULL
the	NULL
IL-3-induced	NULL
response	NULL
(	NULL
lane	NULL
3	NULL
compared	NULL
to	NULL
lane	NULL
6	NULL
;	NULL
lane	NULL
9	NULL
compared	NULL
to	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
CIS	NULL
on	NULL
IL-2-	NULL
and	NULL
IL-3-induced	NULL
STAT5b	NULL
phosphorylation	NULL
.	NULL

Clones	NULL
in	NULL
which	NULL
CIS	NULL
expression	NULL
is	NULL
suppressed	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
were	NULL
established	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
IL-2	NULL
or	NULL
IL-3	NULL
for	NULL
15	NULL
min	NULL
;	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
cells	NULL
removed	NULL
from	NULL
tetracycline	NULL
for	NULL
36	NULL
h	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
CIS	NULL
or	NULL
SOCS-3	NULL
in	NULL
comparison	NULL
to	NULL
cells	NULL
maintained	NULL
in	NULL
tetracycline	NULL
.	NULL

There	NULL
was	NULL
no	NULL
detectable	NULL
inhibition	NULL
of	NULL
IL-2-	NULL
and	NULL
IL-3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
5b	NULL
in	NULL
cells	NULL
expressing	NULL
CIS	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
,	NULL
but	NULL
again	NULL
SOCS-3	NULL
expression	NULL
induced	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
IL-2-mediated	NULL
STAT	NULL
5b	NULL
phosphorylation	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
CIS	NULL
THE	NULL
SOCS-3	NULL
PHOSPHOPROTEIN	NULL
REGULATES	NULL
IL-2	NULL
RESPONSES	NULL
-	NULL
4985	NULL
does	NULL
not	NULL
affect	NULL
IL-2-mediated	NULL
STATS5b	NULL
activation	NULL
as	NULL
potently	NULL
as	NULL
can	NULL
SOCS-3	NULL
.	NULL

SOCS-3	NULL
partially	NULL
inhibits	NULL
IL-2R	NULL
and	NULL
Jak1	NULL
phosphorylation	NULL
.	NULL

We	NULL
performed	NULL
experiments	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
above	NULL
in	NULL
which	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
antibody	NULL
to	NULL
IL-2RfB	NULL
,	NULL
in	NULL
cells	NULL
with	NULL
and	NULL
without	NULL
SOCS-3	NULL
.	NULL

Induction	NULL
of	NULL
SOCS-3	NULL
(	NULL
by	NULL
removal	NULL
from	NULL
tetracycline	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
small	NULL
but	NULL
consistent	NULL
reduction	NULL
of	NULL
IL-2-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
receptor	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Following	NULL
SOCS-3	NULL
induction	NULL
,	NULL
there	NULL
was	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
the	NULL
level	NULL
of	NULL
tyrosine-phosphorylated	NULL
Jak1	NULL
associated	NULL
with	NULL
IL-2R	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
although	NULL
there	NULL
was	NULL
no	NULL
apparent	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
Jak1	NULL
associated	NULL
with	NULL
the	NULL
receptor	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
second	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
no	NULL
detectable	NULL
reduction	NULL
in	NULL
IL-3-induced	NULL
IL-3R	NULL
$	NULL
,	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
observed	NULL
following	NULL
removal	NULL
of	NULL
tetracycline	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

SOCS-3	NULL
inhibits	NULL
IL-2-	NULL
and	NULL
IL-3-mediated	NULL
proliferation	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
SOCS-3	NULL
and	NULL
CIS	NULL
expression	NULL
on	NULL
IL-2-mediated	NULL
proliferation	NULL
in	NULL
BaF3	NULL
cells	NULL
expressing	NULL
IL-2RfB	NULL
.	NULL

Again	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
for	NULL
36	NULL
h	NULL
,	NULL
including	NULL
12	NULL
h	NULL
free	NULL
from	NULL
cytokine	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subsequently	NULL
incubated	NULL
in	NULL
medium	NULL
either	NULL
with	NULL
or	NULL
without	NULL
cytokine	NULL
(	NULL
IL-2	NULL
[	NULL
100	NULL
U/ml	NULL
]	NULL
or	NULL
IL-3	NULL
[	NULL
50	NULL
U/mI	NULL
]	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
levels	NULL
of	NULL
DNA	NULL
synthesis	NULL
were	NULL
measured	NULL
by	NULL
incorporation	NULL
of	NULL
[	NULL
°HJthymidine	NULL
.	NULL

Cells	NULL
expressing	NULL
SOCS-3	NULL
had	NULL
markedly	NULL
reduced	NULL
levels	NULL
of	NULL
thymidine	NULL
incorporation	NULL
in	NULL
response	NULL
to	NULL
both	NULL
IL-2	NULL
and	NULL
IL-3	NULL
compared	NULL
to	NULL
clones	NULL
that	NULL
had	NULL
been	NULL
left	NULL
in	NULL
tetracycline	NULL
and	NULL
that	NULL
did	NULL
not	NULL
express	NULL
SOCS-3	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
smaller	NULL
reductions	NULL
in	NULL
thymidine	NULL
incorporation	NULL
were	NULL
noted	NULL
in	NULL
cells	NULL
that	NULL
expressed	NULL
CIS	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
representative	NULL
of	NULL
six	NULL
individual	NULL
experiments	NULL
and	NULL
demonstrate	NULL
that	NULL
induced	NULL
expression	NULL
of	NULL
SOCS-3	NULL
can	NULL
more	NULL
strongly	NULL
suppress	NULL
IL-2	NULL
(	NULL
and	NULL
IL-3	NULL
)	NULL
prolifer-ative	NULL
responses	NULL
than	NULL
does	NULL
expression	NULL
of	NULL
CIS	NULL
.	NULL

DISCUSSION	NULL
Signaling	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
to	NULL
cytokines	NULL
such	NULL
as	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-15	NULL
(	NULL
which	NULL
signal	NULL
through	NULL
y	NULL
,	NULL
,	NULL
Jak1	NULL
,	NULL
and	NULL
Jak3	NULL
)	NULL
is	NULL
known	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
normal	NULL
lymphocyte	NULL
development	NULL
and	NULL
proliferation	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Although	NULL
much	NULL
is	NULL
understood	NULL
with	NULL
respect	NULL
to	NULL
how	NULL
activating	NULL
signals	NULL
are	NULL
transduced	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
their	NULL
control	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
induction	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SOCS-3	NULL
in	NULL
lymphocytes	NULL
,	NULL
including	NULL
in	NULL
human	NULL
PBLs	NULL
,	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
report	NULL
that	NULL
it	NULL
interacts	NULL
with	NULL
IL-ZR	NULL
and	NULL
Jak1	NULL
.	NULL

We	NULL
show	NULL
that	NULL
SOCS-3	NULL
is	NULL
strongly	NULL
phosphorylated	NULL
by	NULL
Jak1	NULL
,	NULL
that	NULL
SOCS-3	NULL
can	NULL
inhibit	NULL
Jak1	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
and	NULL
that	NULL
this	NULL
inhibition	NULL
is	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
IL-ZRB	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
SOCS-3	NULL
can	NULL
abrogate	NULL
IL-2-induced	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STATS	NULL
and	NULL
IL-2-mediated	NULL
proliferation	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
lymphocytes	NULL
SOCS-3	NULL
can	NULL
regulate	NULL
IL-2	NULL
responses	NULL
.	NULL

Cytokines	NULL
induce	NULL
SOCS/CIS/SSI	NULL
family	NULL
members	NULL
as	NULL
immediate-early	NULL
genes	NULL
(	NULL
7	NULL
,	NULL
17	NULL
,	NULL
26	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
SOCS-3	NULL
protein	NULL
is	NULL
particularly	NULL
rapidly	NULL
induced	NULL
and	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
human	NULL
PBLs	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
,	NULL
being	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
30	NULL
min	NULL
following	NULL
stimulation	NULL
.	NULL

This	NULL
family	NULL
of	NULL
proteins	NULL
are	NULL
also	NULL
rapidly	NULL
degraded	NULL
,	NULL
suggesting	NULL
that	NULL
SOCS	NULL
protein	NULL
function	NULL
is	NULL
only	NULL
transiently	NULL
required	NULL
.	NULL

In	NULL
Kit-225	NULL
cells	NULL
,	NULL
SOCS-3	NULL
levels	NULL
fall	NULL
within	NULL
4	NULL
h	NULL
,	NULL
while	NULL
in	NULL
PBLs	NULL
they	NULL
decline	NULL
after	NULL
1	NULL
h	NULL
;	NULL
in	NULL
com-parison	NULL
,	NULL
CIS	NULL
is	NULL
strongly	NULL
detected	NULL
between	NULL
4	NULL
and	NULL
12	NULL
h.	NULL
Interestingly	NULL
,	NULL
CIS	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
subject	NULL
to	NULL
ubiquitination	NULL
and	NULL
to	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
pathway	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
described	NULL
,	NULL
addition	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
resulted	NULL
in	NULL
significant	NULL
accumulation	NULL
of	NULL
both	NULL
the	NULL
ubiquitinated	NULL
CIS	NULL
and	NULL
CIS-EPOR	NULL
complexes	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
normally	NULL
present	NULL
only	NULL
transiently	NULL
;	NULL
furthermore	NULL
,	NULL
proteasome	NULL
inhibition	NULL
4986	NULL
COHNEY	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
S3	NULL
CL2	NULL
$	NULL
3	NULL
CL3	NULL
Tet	NULL
int	NULL
T	NULL
~	NULL
+	NULL
IP	NULL
:	NULL
«	NULL
STAT5b	NULL
Tc	NULL
iz	NULL
usc	NULL
inz	NULL
sé	NULL
itz	NULL
ius	NULL
1	NULL
c	NULL
itz	NULL
is	NULL
]	NULL
C	NULL
Blot	NULL
:	NULL
«	NULL
PTyr	NULL
98	NULL
-	NULL
\	NULL
_	NULL
*~	NULL
»	NULL
moms	NULL
wat	NULL
__	NULL
watt	NULL
a-STAT5D	NULL
\	NULL
64	NULL
«	NULL
ma	NULL
greg	NULL
wap	NULL
o	NULL
--	NULL
qee	NULL
50	NULL
-	NULL
<	NULL
ga	NULL
m	NULL
:	NULL
en	NULL
pa	NULL
go	NULL
at	NULL
wen	NULL
®	NULL
&	NULL
veg	NULL
Basin	NULL
=	NULL
,	NULL
Blot	NULL
:	NULL
«	NULL
STATSb	NULL
a	NULL
&	NULL
P	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
CL2	NULL
CL3	NULL
Tet	NULL
-	NULL
4	NULL
=-36	NULL
-	NULL
yoo	NULL
oat	NULL
IP	NULL
:	NULL
«	NULL
SOCS-3	NULL
'	NULL
t	NULL
Blot	NULL
:	NULL
«	NULL
SOCS-3	NULL
30	NULL
-	NULL
n	NULL
“	NULL
<	NULL
-socs-3	NULL
B	NULL
§0CS-3	NULL
CIS	NULL
C	NULL
Tet	NULL
_*	NULL
~	NULL
D	NULL
Tet	NULL
_+	NULL
*	NULL
Tet	NULL
*	NULL
+	NULL
=	NULL
+	NULL
IP	NULL
:	NULL
a	NULL
STAT5b	NULL
C	NULL
iL-21	NULL
!	NULL

c	NULL
11-2	NULL
o	NULL
L3	NULL
C	NULL
L3	NULL
ie	NULL
as	NULL
Ifo	NULL
is	NULL
fee	NULL
t	NULL
1	NULL
Blot	NULL
:	NULL
a	NULL
PTyr	NULL
250	NULL
-	NULL
'	NULL
IP	NULL
:	NULL
o-IL-2RB	NULL
f	NULL
Blot	NULL
:	NULL
o-PTyr	NULL
250	NULL
-	NULL
IP	NULL
:	NULL
Bq	NULL
#	NULL
-	NULL
wt	NULL
0	NULL
um	NULL
tib	NULL
=	NULL
owl	NULL
=	NULL
atu	NULL
<	NULL
-	NULL
STATSb	NULL
Blot	NULL
:	NULL
o-PTyr	NULL
<	NULL
-	NULL
JAK	NULL
1	NULL
M-	NULL
98	NULL
-	NULL
®	NULL
_	NULL
wo	NULL
&	NULL
<	NULL
4	NULL
$	NULL
-	NULL
“	NULL
QC-n-	NULL
<	NULL
n	NULL
ame	NULL
ame	NULL
&	NULL
$	NULL
4	NULL
-	NULL
.	NULL

*	NULL
'	NULL
98	NULL
win	NULL
d	NULL
Blot	NULL
:	NULL
a	NULL
STAT5b	NULL
Blot	NULL
:	NULL
o-Jak	NULL
1	NULL
W	NULL
<	NULL
4-	NULL
STAT5b	NULL
its	NULL
wt	NULL
mas	NULL
tal	NULL
'	NULL
!	NULL

.-	NULL
Blot	NULL
:	NULL
0-Bq	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
...	NULL
~	NULL
Blot	NULL
:	NULL
o-IL-2RB	NULL
socs-3	NULL
CIS	NULL
'	NULL
``	NULL
an	NULL
sy	NULL
IP	NULL
:	NULL
«	NULL
-80cS-3	NULL
36	NULL
-	NULL
MD	NULL
<	NULL
-cis	NULL
Blot	NULL
:	NULL
«	NULL
-SOCS-3	NULL
|	NULL
Sewn	NULL
~*	NULL
awe	NULL
<	NULL
-	NULL
socs-3	NULL
so	NULL
_	NULL
t®e	NULL
<	NULL
4-socs-3	NULL
Tet	NULL
+	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

SOCS-3	NULL
but	NULL
not	NULL
CIS	NULL
inhibits	NULL
IL-2-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS5b	NULL
and	NULL
Jak1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Two	NULL
BaF3	NULL
clones	NULL
(	NULL
S3	NULL
CL2	NULL
and	NULL
$	NULL
3	NULL
CL3	NULL
)	NULL
expressing	NULL
IL-2RB	NULL
,	NULL
in	NULL
which	NULL
SOCS-3	NULL
was	NULL
absent	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
tet	NULL
)	NULL
(	NULL
+	NULL
)	NULL
or	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
SOCS-3	NULL
was	NULL
induced	NULL
by	NULL
removal	NULL
from	NULL
tetracycline	NULL
(	NULL
-	NULL
)	NULL
,	NULL
were	NULL
treated	NULL
with	NULL
IL-2	NULL
or	NULL
IL-3	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
subject	NULL
to	NULL
immunoblotting	NULL
with	NULL
antiphosphotyrosine	NULL
(	NULL
«	NULL
PTyr	NULL
)	NULL
and	NULL
immunoprecipitation	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
anti-STAT5b	NULL
.	NULL

SOCS-3	NULL
levels	NULL
were	NULL
checked	NULL
by	NULL
immunoblotting	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
BaF3	NULL
clones	NULL
in	NULL
which	NULL
CIS	NULL
or	NULL
SOCS-3	NULL
expression	NULL
was	NULL
controlled	NULL
by	NULL
removal	NULL
from	NULL
tetracycline	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
antiphosphotyrosine	NULL
and	NULL
anti-STAT5b	NULL
.	NULL

CIS	NULL
and	NULL
SOCS-3	NULL
levels	NULL
were	NULL
checked	NULL
by	NULL
immunoblotting	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
SOCS-3-expressing	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
ab	NULL
ove	NULL
with	NULL
IL-2	NULL
,	NULL
immunoprecipitated	NULL
anti-IL-2RB	NULL
,	NULL
and	NULL
blotted	NULL
for	NULL
phosphotyrosine	NULL
(	NULL
C	NULL
,	NULL
top	NULL
)	NULL
,	NULL
Jak1	NULL
(	NULL
C	NULL
,	NULL
middle	NULL
)	NULL
,	NULL
or	NULL
(	NULL
C	NULL
,	NULL
bottom	NULL
)	NULL
or	NULL
with	NULL
IL-3	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
anti-IL-3RfB	NULL
,	NULL
,	NULL
and	NULL
blotted	NULL
for	NULL
antiphosphotyrosine	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

also	NULL
prolonged	NULL
the	NULL
phosphorylation	NULL
of	NULL
both	NULL
the	NULL
EPOR	NULL
and	NULL
STATS	NULL
.	NULL

The	NULL
proteasome	NULL
inhibitors	NULL
LLaL	NULL
and	NULL
LLM	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
stabilize	NULL
SOCS-1	NULL
expression	NULL
in	NULL
M1	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

It	NULL
had	NULL
previously	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
proteasome	NULL
pathway	NULL
contributes	NULL
to	NULL
regulation	NULL
of	NULL
the	NULL
IL-2-stimulated	NULL
Jak-STAT	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
30	NULL
)	NULL
,	NULL
although	NULL
neither	NULL
STATS	NULL
nor	NULL
Jak	NULL
kinase	NULL
appears	NULL
to	NULL
be	NULL
ubiquitinated	NULL
(	NULL
5	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ubiquitination	NULL
of	NULL
the	NULL
SOCS	NULL
proteins	NULL
and	NULL
their	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
might	NULL
account	NULL
for	NULL
their	NULL
rapid	NULL
turnover	NULL
and	NULL
may	NULL
be	NULL
a	NULL
means	NULL
by	NULL
which	NULL
they	NULL
modulate	NULL
cytokine	NULL
signaling	NULL
pathways	NULL
.	NULL

SOCS-3	NULL
is	NULL
unusual	NULL
among	NULL
SOCS	NULL
family	NULL
members	NULL
with	NULL
regard	NULL
to	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
was	NULL
detectable	NULL
in	NULL
both	NULL
Kit-225	NULL
cells	NULL
and	NULL
PBLs	NULL
as	NULL
carly	NULL
as	NULL
protein	NULL
was	NULL
observed	NULL
.	NULL

SOCS-3	NULL
was	NULL
strongly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Jak1	NULL
in	NULL
293	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
while	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
also	NULL
seen	NULL
with	NULL
Jak2	NULL
and	NULL
Lok	NULL
,	NULL
it	NULL
was	NULL
sig-	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
Tet	NULL
4	NULL
CIS	NULL
=	NULL
|	NULL
|	NULL
50000	NULL
40000	NULL
&	NULL
_	NULL
§	NULL
.	NULL

-	NULL
soo00	NULL
9	NULL
20000	NULL
-	NULL
L	NULL
I	NULL
10000	NULL
IL-3	NULL
IL-2	NULL
Med	NULL
-	NULL
IL-2	NULL
Med	NULL
THE	NULL
SOCS-3	NULL
PHOSPHOPROTEIN	NULL
REGULATES	NULL
IL-2	NULL
RESPONSES	NULL
-	NULL
4987	NULL
B	NULL
socs-3	NULL
TetI	NULL
+	NULL
f	NULL
o	NULL
--	NULL
]	NULL
60000	NULL
-	NULL
~	NULL
o	NULL
mo	NULL
eo	NULL
50000	NULL
40000	NULL
-	NULL
I	NULL
30000	NULL
-	NULL
|	NULL
1	NULL
I	NULL
20000	NULL
cpm	NULL
10000	NULL
0	NULL
IL-3	NULL
IL-2	NULL
Med	NULL
JL-3	NULL
IL-2	NULL
Med	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

SOCS-3	NULL
inhibits	NULL
cytokine-induced	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

Lymphocyte	NULL
proliferation	NULL
was	NULL
assessed	NULL
by	NULL
[	NULL
*H|thymidine	NULL
incorporation	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
on	NULL
BaF3	NULL
clones	NULL
(	NULL
expressing	NULL
CIS	NULL
[	NULL
A	NULL
]	NULL
or	NULL
SOCS-3	NULL
[	NULL
B	NULL
]	NULL
)	NULL
,	NULL
in	NULL
which	NULL
SOCS-3	NULL
was	NULL
absent	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
Tet	NULL
)	NULL
(	NULL
+	NULL
)	NULL
or	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
SOCS-3	NULL
was	NULL
induced	NULL
by	NULL
removal	NULL
from	NULL
tetracycline	NULL
(	NULL
-	NULL
)	NULL
.	NULL

SOCS-3	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
was	NULL
confirmed	NULL
by	NULL
immunoblotting	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Med	NULL
,	NULL
cytokine-free	NULL
medium	NULL
.	NULL

nificantly	NULL
lower	NULL
with	NULL
Jak3	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
region	NULL
between	NULL
the	NULL
SH2	NULL
domain	NULL
and	NULL
the	NULL
SOCS	NULL
box	NULL
may	NULL
explain	NULL
the	NULL
propensity	NULL
of	NULL
SOCS-3	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
comparison	NULL
to	NULL
other	NULL
SOCS	NULL
proteins	NULL
.	NULL

While	NULL
the	NULL
precise	NULL
role	NULL
and	NULL
importance	NULL
of	NULL
this	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
unknown	NULL
,	NULL
the	NULL
strict	NULL
regulation	NULL
of	NULL
SOCS-3	NULL
through	NULL
both	NULL
rapid	NULL
changes	NULL
in	NULL
protein	NULL
levels	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
further	NULL
point	NULL
to	NULL
an	NULL
important	NULL
role	NULL
for	NULL
SOCS-3	NULL
in	NULL
the	NULL
IL-2	NULL
response	NULL
.	NULL

It	NULL
is	NULL
apparent	NULL
that	NULL
cytokine	NULL
signaling	NULL
can	NULL
be	NULL
controlled	NULL
by	NULL
a	NULL
number	NULL
of	NULL
mechanisms	NULL
.	NULL

Phosphatases	NULL
are	NULL
known	NULL
to	NULL
regulate	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
,	NULL
a	NULL
classic	NULL
example	NULL
being	NULL
the	NULL
SHZ-containing	NULL
tyrosine	NULL
phosphatase	NULL
SHP-1	NULL
,	NULL
which	NULL
is	NULL
recruited	NULL
to	NULL
a	NULL
number	NULL
of	NULL
activated	NULL
cytokine	NULL
receptors	NULL
,	NULL
including	NULL
IL-4R	NULL
,	NULL
EPOR	NULL
,	NULL
IL-3R	NULL
,	NULL
and	NULL
the	NULL
IL-ZR	NULL
(	NULL
19	NULL
)	NULL
.	NULL

IL-2	NULL
responses	NULL
are	NULL
also	NULL
thought	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
degradation	NULL
of	NULL
receptor	NULL
components	NULL
such	NULL
as	NULL
the	NULL
calpain-mediated	NULL
cleavage	NULL
of	NULL
y	NULL
,	NULL
,	NULL
(	NULL
21	NULL
)	NULL
and	NULL
by	NULL
receptor	NULL
internalization	NULL
.	NULL

A	NULL
family	NULL
of	NULL
PIAS	NULL
proteins	NULL
that	NULL
are	NULL
thought	NULL
to	NULL
interact	NULL
with	NULL
STATs	NULL
and	NULL
inhibit	NULL
their	NULL
activity	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Clearly	NULL
,	NULL
many	NULL
mechanisms	NULL
may	NULL
contribute	NULL
to	NULL
downregulation	NULL
of	NULL
the	NULL
stimulatory	NULL
response	NULL
,	NULL
and	NULL
the	NULL
SOCS	NULL
proteins	NULL
add	NULL
yet	NULL
another	NULL
level	NULL
of	NULL
control	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
SOCS	NULL
proteins	NULL
for	NULL
individual	NULL
cytokine	NULL
responses	NULL
remains	NULL
uncertain	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
CIS	NULL
,	NULL
the	NULL
only	NULL
established	NULL
interactions	NULL
are	NULL
with	NULL
EPOR	NULL
and	NULL
IL-3R	NULL
signaling	NULL
through	NULL
which	NULL
CIS	NULL
can	NULL
partially	NULL
inhibit	NULL
(	NULL
13	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
also	NULL
find	NULL
that	NULL
CIS	NULL
can	NULL
partially	NULL
inhibit	NULL
IL-2	NULL
responses	NULL
,	NULL
although	NULL
the	NULL
effects	NULL
are	NULL
less	NULL
potent	NULL
than	NULL
those	NULL
observed	NULL
with	NULL
SOCS-3	NULL
.	NULL

SOCS-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
strongly	NULL
inhibit	NULL
IL-6-mediated	NULL
signaling	NULL
in	NULL
M1	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
17	NULL
,	NULL
26	NULL
)	NULL
,	NULL
and	NULL
both	NULL
SOCS-1	NULL
and	NULL
SOCS-3	NULL
can	NULL
inhibit	NULL
LIF	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
-	NULL
and	NULL
GH	NULL
(	NULL
1	NULL
)	NULL
-mediated	NULL
signaling	NULL
.	NULL

LIF	NULL
induces	NULL
SOCS-3	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
hypothalamus	NULL
,	NULL
and	NULL
more	NULL
dramatically	NULL
in	NULL
the	NULL
pituitary	NULL
,	NULL
of	NULL
mice	NULL
,	NULL
and	NULL
in	NULL
AT	NULL
-20	NULL
corticotroph	NULL
cells	NULL
,	NULL
stable	NULL
overexpression	NULL
of	NULL
SOCS-3	NULL
reduced	NULL
LIF-mediated	NULL
receptor	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
and	NULL
adenocorticotropin	NULL
secretion	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Leptin	NULL
was	NULL
shown	NULL
to	NULL
induce	NULL
hypothalamic	NULL
SOCS-3	NULL
mRNA	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
SOCS-3	NULL
was	NULL
able	NULL
to	NULL
inhibit	NULL
leptin-induced	NULL
receptor	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
clear	NULL
that	NULL
SOCS-3	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
.	NULL

SOCS-1-deficient	NULL
mice	NULL
have	NULL
been	NULL
generated	NULL
and	NULL
are	NULL
reported	NULL
to	NULL
have	NULL
small	NULL
thymuses	NULL
;	NULL
though	NULL
healthy	NULL
at	NULL
birth	NULL
,	NULL
they	NULL
exhibit	NULL
stunted	NULL
growth	NULL
and	NULL
pro	NULL
gressive	NULL
lymphocytopenia	NULL
and	NULL
die	NULL
before	NULL
weaning	NULL
in	NULL
association	NULL
with	NULL
fatty	NULL
degeneration	NULL
and	NULL
monocytic	NULL
infiltration	NULL
of	NULL
the	NULL
liver	NULL
(	NULL
16	NULL
,	NULL
25	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
SOCS-1	NULL
has	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
homeostasis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
SOCS	NULL
family	NULL
members	NULL
inhibit	NULL
signaling	NULL
appear	NULL
to	NULL
differ	NULL
.	NULL

CIS	NULL
can	NULL
interact	NULL
with	NULL
tyrosine-phosphorylated	NULL
forms	NULL
of	NULL
IL-3RfB	NULL
,	NULL
,	NULL
and	NULL
the	NULL
EPOR	NULL
(	NULL
29	NULL
)	NULL
,	NULL
associating	NULL
with	NULL
a	NULL
known	NULL
STATS	NULL
binding	NULL
site	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Alterna-tively	NULL
,	NULL
following	NULL
ubiquitination	NULL
,	NULL
CIS	NULL
may	NULL
chaperone	NULL
the	NULL
receptor	NULL
into	NULL
the	NULL
proteasome	NULL
pathway	NULL
as	NULL
alluded	NULL
to	NULL
earlier	NULL
(	NULL
28	NULL
)	NULL
.	NULL

While	NULL
the	NULL
effect	NULL
of	NULL
CIS	NULL
seems	NULL
to	NULL
be	NULL
mediated	NULL
primarily	NULL
through	NULL
interaction	NULL
with	NULL
the	NULL
receptor	NULL
,	NULL
SOCS-1	NULL
was	NULL
cloned	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
Jak2	NULL
(	NULL
through	NULL
its	NULL
JH1	NULL
kinase	NULL
domain	NULL
)	NULL
and	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
interact	NULL
with	NULL
and	NULL
inhibit	NULL
members	NULL
of	NULL
the	NULL
Jak	NULL
family	NULL
(	NULL
7	NULL
)	NULL
.	NULL

A	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
showed	NULL
that	NULL
SOCS-3	NULL
could	NULL
also	NULL
interact	NULL
with	NULL
the	NULL
JH1	NULL
domain	NULL
of	NULL
Jak2	NULL
and	NULL
the	NULL
lymphocyte-specific	NULL
kinase	NULL
Lok	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
SOCS-3	NULL
can	NULL
interact	NULL
with	NULL
Jak1	NULL
and	NULL
inhibit	NULL
its	NULL
activity	NULL
,	NULL
but	NULL
the	NULL
enhanced	NULL
inhibition	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-Z2RB	NULL
suggests	NULL
that	NULL
the	NULL
receptor	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
facilitating	NULL
SOCS-3	NULL
action	NULL
.	NULL

The	NULL
SOCS-3	NULL
fusion	NULL
protein	NULL
was	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
Jak1	NULL
and	NULL
IL-2RB	NULL
only	NULL
after	NULL
the	NULL
IL-2-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
receptor	NULL
complex	NULL
;	NULL
this	NULL
is	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
requirement	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
targets	NULL
of	NULL
both	NULL
SOCS-1	NULL
(	NULL
18	NULL
)	NULL
and	NULL
CIS	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
previous	NULL
yeast	NULL
two-hybrid	NULL
studies	NULL
failed	NULL
to	NULL
show	NULL
an	NULL
interaction	NULL
between	NULL
SOCS-3	NULL
and	NULL
IL-Z2RB	NULL
,	NULL
possibly	NULL
because	NULL
of	NULL
this	NULL
dependence	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
whether	NULL
the	NULL
interaction	NULL
of	NULL
SOCS-3	NULL
with	NULL
the	NULL
receptor	NULL
is	NULL
direct	NULL
or	NULL
if	NULL
it	NULL
occurs	NULL
solely	NULL
through	NULL
the	NULL
binding	NULL
of	NULL
SOCS-3	NULL
to	NULL
Jak1	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
receptor	NULL
.	NULL

It	NULL
is	NULL
of	NULL
note	NULL
that	NULL
SOCS-3	NULL
did	NULL
not	NULL
significantly	NULL
inhibit	NULL
IL-3-mediated	NULL
STATS	NULL
phosphorylation	NULL
,	NULL
even	NULL
though	NULL
IL-3R	NULL
signals	NULL
through	NULL
Jak1	NULL
and	NULL
Jak2	NULL
.	NULL

Also	NULL
of	NULL
note	NULL
,	NULL
CIS	NULL
did	NULL
not	NULL
inhibit	NULL
cytokine-mediated	NULL
Stat5b	NULL
phosphorylation	NULL
,	NULL
suggesting	NULL
that	NULL
SOCS-3	NULL
may	NULL
specifically	NULL
mediate	NULL
this	NULL
effect	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
gamma	NULL
interferon	NULL
signaling	NULL
(	NULL
which	NULL
uses	NULL
both	NULL
Jak1	NULL
and	NULL
Jak2	NULL
)	NULL
is	NULL
inhibited	NULL
by	NULL
SOCS-1	NULL
but	NULL
not	NULL
SOCS-3	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
while	NULL
SOCS-3	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
inhibit	NULL
Jak	NULL
activity	NULL
,	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
inhibition	NULL
may	NULL
be	NULL
receptor	NULL
dependent	NULL
;	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
IL-2	NULL
response	NULL
,	NULL
the	NULL
interaction	NULL
with	NULL
both	NULL
IL-2R	NULL
and	NULL
Jak1	NULL
(	NULL
rath-er	NULL
than	NULL
Jak3	NULL
)	NULL
seem	NULL
pivotal	NULL
.	NULL

4988	NULL
COHNEY	NULL
ET	NULL
AL	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
inhibitory	NULL
effect	NULL
SOCS-3	NULL
exerted	NULL
on	NULL
IL-2-induced	NULL
STATS	NULL
phosphorylation	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
significant	NULL
inhibition	NULL
of	NULL
both	NULL
IL-2-	NULL
and	NULL
IL-3-mediated	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
SOCS-1	NULL
to	NULL
inhibit	NULL
responses	NULL
to	NULL
various	NULL
cytokines	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
the	NULL
marked	NULL
effect	NULL
on	NULL
STATS	NULL
phosphorylation	NULL
,	NULL
SOCS-3	NULL
did	NULL
not	NULL
completely	NULL
inhibit	NULL
IL-2-induced	NULL
receptor	NULL
phosphorylation	NULL
and	NULL
proliferation	NULL
,	NULL
suggesting	NULL
that	NULL
not	NULL
all	NULL
responses	NULL
to	NULL
IL-2	NULL
are	NULL
blocked	NULL
by	NULL
SOCS-3	NULL
expression	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
SOCS-3	NULL
inhibits	NULL
IL-3-mediated	NULL
proliferation	NULL
is	NULL
unclear	NULL
but	NULL
may	NULL
be	NULL
independent	NULL
of	NULL
Stat5b	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
findings	NULL
indicate	NULL
that	NULL
in	NULL
lymphocytes	NULL
,	NULL
SOCS-3	NULL
is	NULL
strongly	NULL
and	NULL
rapidly	NULL
expressed	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
(	NULL
and	NULL
perhaps	NULL
other	NULL
cytokines	NULL
)	NULL
and	NULL
can	NULL
interact	NULL
with	NULL
IL-2R	NULL
and	NULL
Jak1	NULL
,	NULL
following	NULL
which	NULL
it	NULL
inhibits	NULL
further	NULL
IL-2	NULL
responses	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
SOCS-3	NULL
in	NULL
human	NULL
PBLs	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
is	NULL
of	NULL
particular	NULL
importance	NULL
in	NULL
light	NULL
of	NULL
the	NULL
continuing	NULL
uncertainty	NULL
of	NULL
the	NULL
precise	NULL
physiological	NULL
role	NULL
(	NULL
s	NULL
)	NULL
of	NULL
SOCS	NULL
proteins	NULL
.	NULL

This	NULL
find-ing	NULL
,	NULL
coupled	NULL
with	NULL
its	NULL
rapid	NULL
induction	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
and	NULL
ability	NULL
to	NULL
inhibit	NULL
IL-2-mediated	NULL
proliferation	NULL
,	NULL
suggest	NULL
an	NULL
important	NULL
role	NULL
in	NULL
controlling	NULL
lymphocyte	NULL
function	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Ronald	NULL
Herbst	NULL
for	NULL
critical	NULL
comments	NULL
and	NULL
technical	NULL
help	NULL
,	NULL
and	NULL
we	NULL
thank	NULL
Maribel	NULL
Andonian	NULL
and	NULL
Gary	NULL
Burget	NULL
for	NULL
graphics	NULL
.	NULL

DNAX	NULL
Research	NULL
Institute	NULL
is	NULL
supported	NULL
by	NULL
Schering	NULL
Plough	NULL
Corpo-ration	NULL
.	NULL

S.	NULL
Cohney	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
Jacquot	NULL
Travelling	NULL
Fellowship	NULL
from	NULL
the	NULL
Royal	NULL
Australasian	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
by	NULL
the	NULL
Australian	NULL
&	NULL
New	NULL
Zealand	NULL
Society	NULL
of	NULL
Nephrology	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adams	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hansen	NULL
,	NULL
R.	NULL
Starr	NULL
,	NULL
N.	NULL
A.	NULL
Nicola	NULL
,	NULL
D.	NULL
J.	NULL
Hilton	NULL
,	NULL
and	NULL
N.	NULL
Billestrup	NULL
.	NULL

1998	NULL
.	NULL

Growth	NULL
hormone	NULL
preferentially	NULL
induces	NULL
the	NULL
rapid	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
SOCS-3	NULL
,	NULL
a	NULL
novel	NULL
inhibitor	NULL
of	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:1285-1287	NULL
.	NULL

2	NULL
.	NULL

Auernh	NULL
C.	NULL
J.	NULL
,	NULL
v.	NULL
Ch	NULL
kova	NULL
,	NULL
C.	NULL
Bousquet	NULL
,	NULL
and	NULL
S.	NULL
Melmed	NULL
.	NULL

1998	NULL
.	NULL

Pituitary	NULL
corticotroph	NULL
SOCS-3	NULL
:	NULL
novel	NULL
intracellular	NULL
regulation	NULL
of	NULL
leukemia-inhibitory	NULL
factor-mediated	NULL
proopiomelanocortin	NULL
gene	NULL
expression	NULL
and	NULL
adre-nocorticotropin	NULL
secretion	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

12:954-961	NULL
.	NULL

3	NULL
.	NULL

Bjorback	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
K.	NULL
Elmquist	NULL
,	NULL
J.	NULL
D.	NULL
Frantz	NULL
,	NULL
S.	NULL
E.	NULL
Shoelson	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Flier	NULL
.	NULL

1998	NULL
.	NULL

Identification	NULL
of	NULL
SOCS-3	NULL
as	NULL
a	NULL
potential	NULL
mediator	NULL
of	NULL
central	NULL
leptin	NULL
resistance	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
1:619-625	NULL
.	NULL

4	NULL
.	NULL

Cacalano	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
Migone	NULL
,	NULL
F.	NULL
Bazan	NULL
,	NULL
E.	NULL
Hanson	NULL
,	NULL
M.	NULL
Chen	NULL
,	NULL
F.	NULL
Candotti	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
.	NULL

1999	NULL
.	NULL

Autosomal	NULL
SCID	NULL
caused	NULL
by	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
N-terminus	NULL
of	NULL
Jak3	NULL
:	NULL
mapping	NULL
of	NULL
the	NULL
Jak3-receptor	NULL
interaction	NULL
domain	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

18:1549-1558	NULL
.	NULL

5	NULL
.	NULL

Callus	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
B.	NULL
Mathey-Prevot	NULL
.	NULL

1998	NULL
.	NULL

Interleukin-3-induced	NULL
activation	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
is	NULL
prolonged	NULL
by	NULL
proteasome	NULL
inhibitors	NULL
.	NULL

Blood	NULL
91:3182-3192	NULL
.	NULL

6	NULL
.	NULL

Chung	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
J.	NULL
Liao	NULL
,	NULL
B.	NULL
Liu	NULL
,	NULL
X.	NULL
Rao	NULL
,	NULL
P.	NULL
Jay	NULL
,	NULL
P.	NULL
Berta	NULL
,	NULL
and	NULL
K.	NULL
Shuai	NULL
.	NULL

1997	NULL
.	NULL

Specific	NULL
inhibition	NULL
of	NULL
Stat3	NULL
signal	NULL
transduction	NULL
by	NULL
PIAS3	NULL
.	NULL

Science	NULL
278:1803-1805	NULL
.	NULL

7	NULL
.	NULL

Endo	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
M.	NULL
Masuhara	NULL
,	NULL
M.	NULL
Yokouchi	NULL
,	NULL
R.	NULL
Suzuki	NULL
,	NULL
H.	NULL
Sakamoto	NULL
,	NULL
K.	NULL
Mitsui	NULL
,	NULL
A.	NULL
Matsumoto	NULL
,	NULL
S.	NULL
Tanimura	NULL
,	NULL
M.	NULL
Ohtsubo	NULL
,	NULL
H.	NULL
Misawa	NULL
,	NULL
T.	NULL
Miyazaki	NULL
,	NULL
N.	NULL
Leonor	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
Y.	NULL
Kanakura	NULL
,	NULL
S.	NULL
Komiya	NULL
,	NULL
and	NULL
A.	NULL
Yoshimura	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
new	NULL
protein	NULL
containing	NULL
an	NULL
SH2	NULL
domain	NULL
that	NULL
inhibits	NULL
JAK	NULL
kinases	NULL
.	NULL

Nature	NULL
387:921-924	NULL
.	NULL

8	NULL
.	NULL

Gossen	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
H.	NULL
Bujard	NULL
.	NULL

1992	NULL
.	NULL

Tight	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
tetracycline-responsive	NULL
promoters	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:5547-51	NULL
.	NULL

9	NULL
.	NULL

Gossen	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Freundlieb	NULL
,	NULL
G.	NULL
Bender	NULL
,	NULL
G.	NULL
Muller	NULL
,	NULL
W.	NULL
Hillen	NULL
,	NULL
and	NULL
H.	NULL
Bujard	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
tetracyclines	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
268:1766-1769	NULL
.	NULL

10	NULL
.	NULL

Hilton	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
R.	NULL
T.	NULL
Richardson	NULL
,	NULL
W.	NULL
S.	NULL
Alexander	NULL
,	NULL
E.	NULL
M.	NULL
Viney	NULL
,	NULL
T.	NULL
A.	NULL
Willson	NULL
,	NULL
N.	NULL
S.	NULL
Sprigg	NULL
,	NULL
R.	NULL
Starr	NULL
,	NULL
S.	NULL
E.	NULL
Nicholson	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Nicola	NULL
.	NULL

1998	NULL
.	NULL

Twenty	NULL
proteins	NULL
containing	NULL
a	NULL
C-terminal	NULL
SOCS	NULL
box	NULL
form	NULL
five	NULL
structural	NULL
classes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:114-119	NULL
.	NULL

11	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
R.	NULL
A.	NULL
Kirken	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
T.	NULL
B.	NULL
Blake	NULL
,	NULL
K.	NULL
Shibuya	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1994	NULL
.	NULL

Phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Nature	NULL
370:151-153	NULL
.	NULL

11a.Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1998	NULL
.	NULL

Jaks	NULL
and	NULL
STATs	NULL
:	NULL
biological	NULL
impli-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

cations	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:293-322	NULL
.	NULL

12	NULL
.	NULL

M	NULL
a	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Sal	NULL
to	NULL
,	NULL
A.	NULL
Mat	NULL
to	NULL
,	NULL
R.	NULL
Suzuki	NULL
,	NULL
H.	NULL
Yasukawa	NULL
,	NULL
K.	NULL
Mitsui	NULL
,	NULL
T.	NULL
Wakioka	NULL
,	NULL
S.	NULL
Tanimura	NULL
,	NULL
A.	NULL
Sasaki	NULL
,	NULL
H.	NULL
Misawa	NULL
,	NULL
M.	NULL
Yokouchi	NULL
,	NULL
M.	NULL
Ohtsubo	NULL
,	NULL
and	NULL
A.	NULL
Yoshimura	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
novel	NULL
CIS	NULL
family	NULL
genes	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

239:439-446	NULL
.	NULL

13	NULL
.	NULL

Matsumoto	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Masuhara	NULL
,	NULL
K.	NULL
Mitsui	NULL
,	NULL
M.	NULL
Yokouchi	NULL
,	NULL
M.	NULL
Ohtsubo	NULL
,	NULL
H.	NULL
Misawa	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
and	NULL
A.	NULL
Yoshimura	NULL
.	NULL

1997	NULL
.	NULL

CIS	NULL
,	NULL
a	NULL
cytokine	NULL
inducible	NULL
SH2	NULL
protein	NULL
,	NULL
is	NULL
a	NULL
target	NULL
of	NULL
the	NULL
JAK-STATS5	NULL
pathway	NULL
and	NULL
modulates	NULL
STATS5	NULL
activation	NULL
.	NULL

Blood	NULL
89:3148-3154	NULL
.	NULL

14	NULL
.	NULL

Minamoto	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Ikegame	NULL
,	NULL
K.	NULL
Ueno	NULL
,	NULL
M.	NULL
Narazaki	NULL
,	NULL
T.	NULL
Naka	NULL
,	NULL
H.	NULL
Yamamoto	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
H.	NULL
Saito	NULL
,	NULL
S.	NULL
Hosoe	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
new	NULL
members	NULL
of	NULL
STAT	NULL
induced	NULL
STAT	NULL
inhibitor	NULL
(	NULL
SST	NULL
)	NULL
family	NULL
:	NULL
SSI-2	NULL
and	NULL
SSI-3	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

237:79-83	NULL
.	NULL

15	NULL
.	NULL

Mui	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
T.	NULL
Kinoshita	NULL
,	NULL
T.	NULL
Kitamura	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
interleukin-3-induced	NULL
gene	NULL
expression	NULL
by	NULL
a	NULL
C-terminal	NULL
truncated	NULL
Stat5	NULL
:	NULL
role	NULL
of	NULL
Stat5	NULL
in	NULL
proliferation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:2425-2433	NULL
.	NULL

16	NULL
.	NULL

Naka	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Narazaki	NULL
,	NULL
M.	NULL
Fujimoto	NULL
,	NULL
Y.	NULL
Morita	NULL
,	NULL
Y.	NULL
Ohsawa	NULL
,	NULL
H.	NULL
Saito	NULL
,	NULL
T.	NULL
Nagasawa	NULL
,	NULL
Y.	NULL
Uchiyama	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1998	NULL
.	NULL

Accelerated	NULL
apoptosis	NULL
of	NULL
lymphocytes	NULL
by	NULL
augmented	NULL
induction	NULL
of	NULL
bax	NULL
in	NULL
SSI-1	NULL
(	NULL
STAT-induced	NULL
STAT	NULL
inhibitor-1	NULL
)	NULL
deficient	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
:	NULL
15577-15582	NULL
.	NULL

17	NULL
.	NULL

Naka	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Narazaki	NULL
,	NULL
M.	NULL
Hirata	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
S.	NULL
Minamoto	NULL
,	NULL
A.	NULL
Aono	NULL
,	NULL
N.	NULL
Nishimoto	NULL
,	NULL
T.	NULL
Kajita	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
K.	NULL
Yoshizaki	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1997	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
new	NULL
STAT-induced	NULL
STAT	NULL
inhibitor	NULL
.	NULL

Nature	NULL
387:924-929	NULL
.	NULL

18	NULL
.	NULL

Narazaki	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Fujimoto	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
Y.	NULL
Morita	NULL
,	NULL
H.	NULL
Saito	NULL
,	NULL
T.	NULL
Kajita	NULL
,	NULL
K.	NULL
Yoshizaki	NULL
,	NULL
T.	NULL
Naka	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1998	NULL
.	NULL

Three	NULL
distinct	NULL
domains	NULL
of	NULL
SSI-1/S5OCS-1/JAB	NULL
protein	NULL
are	NULL
required	NULL
for	NULL
its	NULL
suppression	NULL
of	NULL
interleukin	NULL
6	NULL
signaling	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:13130-13134	NULL
.	NULL

19	NULL
.	NULL

Neel	NULL
,	NULL
B.	NULL
G.	NULL
1997	NULL
.	NULL

Role	NULL
of	NULL
phosphatases	NULL
in	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9405-420	NULL
.	NULL

20	NULL
.	NULL

Nicholson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Hilton	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
SOCS	NULL
proteins	NULL
:	NULL
a	NULL
new	NULL
family	NULL
of	NULL
negative	NULL
regulators	NULL
of	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

63:665-668	NULL
.	NULL

20a.Nicholson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
T.	NULL
A.	NULL
Willson	NULL
,	NULL
A.	NULL
Farley	NULL
,	NULL
R.	NULL
Starr	NULL
,	NULL
J.	NULL
G.	NULL
Zhang	NULL
,	NULL
M.	NULL
Baca	NULL
,	NULL
W.	NULL
S.	NULL
Alexander	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
D.	NULL
J.	NULL
Hilton	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Nicola	NULL
.	NULL

1999	NULL
.	NULL

Mutational	NULL
analyses	NULL
of	NULL
the	NULL
SOCS	NULL
proteins	NULL
suggest	NULL
a	NULL
dual	NULL
domain	NULL
requirement	NULL
but	NULL
distinct	NULL
mechanisms	NULL
for	NULL
inhibition	NULL
of	NULL
LIF	NULL
and	NULL
IL-6	NULL
signal	NULL
transduction	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

18:375-385	NULL
.	NULL

21	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Sarin	NULL
,	NULL
M.	NULL
J.	NULL
Aman	NULL
,	NULL
H.	NULL
Nakajima	NULL
,	NULL
E.	NULL
W.	NULL
Shores	NULL
,	NULL
P.	NULL
A.	NULL
Henkart	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1997	NULL
.	NULL

Functional	NULL
cleavage	NULL
of	NULL
the	NULL
common	NULL
cytokine	NULL
receptor	NULL
gamma	NULL
chain	NULL
(	NULL
gammac	NULL
)	NULL
by	NULL
calpain	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:11534-11539	NULL
.	NULL

22	NULL
.	NULL

O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Notrangelo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
and	NULL
F.	NULL
Candotti	NULL
.	NULL

1997	NULL
.	NULL

Advances	NULL
in	NULL
the	NULL
understanding	NULL
of	NULL
cytokine	NULL
signal	NULL
transduc-tion	NULL
:	NULL
the	NULL
role	NULL
of	NULL
Jaks	NULL
and	NULL
STAT	NULL
's	NULL
in	NULL
immunoregulation	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
immunodeficiency	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

17:431-447	NULL
.	NULL

23	NULL
.	NULL

Resnitzky	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Gossen	NULL
,	NULL
H.	NULL
Bujard	NULL
,	NULL
and	NULL
S.	NULL
I.	NULL
Reed	NULL
.	NULL

1994	NULL
.	NULL

Acceleration	NULL
of	NULL
the	NULL
G/S	NULL
phase	NULL
transition	NULL
by	NULL
expression	NULL
of	NULL
cyclins	NULL
D1	NULL
and	NULL
E	NULL
with	NULL
an	NULL
inducible	NULL
system	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1669-1679	NULL
.	NULL

24	NULL
.	NULL

Sakamoto	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Yasukawa	NULL
,	NULL
M.	NULL
Masubara	NULL
,	NULL
S.	NULL
Tanimura	NULL
,	NULL
A.	NULL
Sasaki	NULL
,	NULL
K.	NULL
Yuge	NULL
,	NULL
M.	NULL
Ohtsubo	NULL
,	NULL
A.	NULL
Ohtsuka	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
T.	NULL
Ohta	NULL
,	NULL
Y.	NULL
Furukawa	NULL
,	NULL
S.	NULL
Iwase	NULL
,	NULL
H.	NULL
Yamada	NULL
,	NULL
and	NULL
A.	NULL
Yoshimura	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
Janus	NULL
kinase	NULL
inhibitor	NULL
,	NULL
JAB	NULL
,	NULL
is	NULL
an	NULL
interferon-gamma-inducible	NULL
gene	NULL
and	NULL
confers	NULL
resistance	NULL
to	NULL
interferons	NULL
.	NULL

Blood	NULL
92:1668-1676	NULL
.	NULL

25	NULL
.	NULL

Starr	NULL
,	NULL
R.	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
A.	NULL
G.	NULL
Elefanty	NULL
,	NULL
M.	NULL
Brysha	NULL
,	NULL
T.	NULL
A.	NULL
Willson	NULL
,	NULL
N.	NULL
A.	NULL
Nicola	NULL
,	NULL
D.	NULL
J.	NULL
Hilton	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
Alexander	NULL
.	NULL

1998	NULL
.	NULL

Liver	NULL
degeneration	NULL
and	NULL
lymphoid	NULL
deficiencies	NULL
in	NULL
mice	NULL
lacking	NULL
suppressor	NULL
of	NULL
cytokine	NULL
signaling-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:14395-14399	NULL
.	NULL

26	NULL
.	NULL

Starr	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
A.	NULL
Willson	NULL
,	NULL
E.	NULL
M.	NULL
Viney	NULL
,	NULL
L.	NULL
J.	NULL
Murray	NULL
,	NULL
J.	NULL
R.	NULL
Rayner	NULL
,	NULL
B.	NULL
J.	NULL
Jenkins	NULL
,	NULL
T.	NULL
J.	NULL
Gonda	NULL
,	NULL
W.	NULL
S.	NULL
Alexander	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
N.	NULL
A.	NULL
Nicola	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Hilton	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
family	NULL
of	NULL
cytokine-inducible	NULL
inhibitors	NULL
of	NULL
signalling	NULL
.	NULL

Nature	NULL
387:917-921	NULL
.	NULL

27	NULL
.	NULL

Takebe	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
P.	NULL
Hoy	NULL
,	NULL
K.	NULL
Yokota	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1988	NULL
.	NULL

SR	NULL
alpha	NULL
promoter	NULL
:	NULL
an	NULL
efficient	NULL
and	NULL
versatile	NULL
mammalian	NULL
cDNA	NULL
expression	NULL
system	NULL
composed	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
and	NULL
the	NULL
R-US	NULL
segment	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8466-472	NULL
.	NULL

28	NULL
.	NULL

Verdier	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Chretien	NULL
,	NULL
O.	NULL
Muller	NULL
,	NULL
P.	NULL
Varlet	NULL
,	NULL
A.	NULL
Yoshimura	NULL
,	NULL
S.	NULL
Gisselbrecht	NULL
,	NULL
C.	NULL
Lacombe	NULL
,	NULL
and	NULL
P.	NULL
Mayeux	NULL
.	NULL

1998	NULL
.	NULL

Proteasomes	NULL
regulate	NULL
erythropoietin	NULL
receptor	NULL
and	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
5	NULL
(	NULL
STATS3	NULL
)	NULL
activation	NULL
.	NULL

Possible	NULL
involvement	NULL
of	NULL
the	NULL
ubiquitinated	NULL
Cis	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:28185-28190	NULL
.	NULL

29	NULL
.	NULL

Yoshimura	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Ohkubo	NULL
,	NULL
T.	NULL
Kiguchi	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
T.	NULL
Hara	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
cytokine-inducible	NULL
gene	NULL
CIS	NULL
encodes	NULL
an	NULL
SH2-containing	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
tyrosine-phosphorylated	NULL
interleukin	NULL
3	NULL
and	NULL
erythropoietin	NULL
receptors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2816-2826	NULL
.	NULL

30	NULL
.	NULL

Yu	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1997	NULL
.	NULL

Involvement	NULL
of	NULL
proteasomes	NULL
in	NULL
regulating	NULL
Jak-STAT	NULL
pathways	NULL
upon	NULL
interleukin-2	NULL
stimulation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
:	NULL
14017-14020	NULL
.	NULL

